Abstract
It has been exciting times since the identification of polycystic kidney disease 1 (PKD1) and PKD2 as the genes mutated in autosomal dominant polycystic kidney disease (ADPKD). Biological roles of the encoded proteins polycystin-1 and TRPP2 have been deduced from phenotypes in ADPKD patients, but recent insights from vertebrate and invertebrate model organisms have significantly expanded our understanding of the physiological functions of these proteins. The identification of additional TRPP (TRPP3 and TRPP5) and polycystin-1-like proteins (PKD1L1, PKD1L2, PKD1L3, and PKDREJ) has added yet another layer of complexity to these fascinating cellular signalling units. TRPP proteins assemble with polycystin-1 family members to form receptor–channel complexes. These protein modules have important biological roles ranging from tubular morphogenesis to determination of left–right asymmetry. The founding members of the polycystin family, TRPP2 and polycystin-1, are a prime example of how studying human disease genes can provide insights into fundamental biological mechanisms using a so-called “reverse translational” approach (from bedside to bench). Here, we discuss the current literature on TRPP ion channels and polycystin-1 family proteins including expression, structure, physical interactions, physiology, and lessons from animal model systems and human disease.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
1 Introduction
The founding member of the TRP polycystin ion channel family, TRPP2, was discovered as a gene product mutated in autosomal dominant polycystic kidney disease (ADPKD) (Mochizuki et al. 1996). The TRPP subfamily may be the most ancient among the TRP channels, as members of this subfamily extend from yeast to mammals (Palmer et al. 2005; Venkatachalam and Montell 2007). TRPP proteins assemble with polycystin-1 family members to form receptor–channel complexes. These protein modules have important biological roles ranging from tubular morphogenesis to determination of left–right asymmetry. TRPP channels have evolutionarily conserved functions in primary cilia where they are thought to translate extracellular cues into cellular signalling events.
This review summarises the current literature on TRPP channels and polycystin-1 family members. Since not all aspects can be covered in this review, the reader is referred to a number of excellent reviews on TRPP channels and polycystin-1 family proteins (Tables 1 and 2) (Somlo 1999; Somlo and Ehrlich 2001; Delmas et al. 2004a; Anyatonwu and Ehrlich 2004; Delmas 2004, 2005; Cantiello 2004; Nilius et al. 2005; Witzgall 2005; Köttgen and Walz 2005; Giamarchi et al. 2006; Köttgen 2007; Harris and Torres 2009; Zhou 2009; Woudenberg-Vrenken et al. 2009; Tsiokas 2009; Hofherr and Köttgen 2011; Hofherr 2012).
2 TRPP Family Genes
The TRPP (polycystin) subfamily of transient receptor potential (TRP) channels displays a rather limited sequence homology to classical TRP genes (Venkatachalam and Montell 2007). The three human genes encoding for the TRPP protein family are: 1) polycystic kidney disease 2 (PKD2); 2) PKD2-like 1 (PKD2L1); and 3) PKD2-like 2 (PKD2L2). PKD2 was identified by linkage analysis in ADPKD patients (Mochizuki et al. 1996; Kimberling et al. 1988; Peters and Sandkuijl 1992). Subsequently, the two PKD2-like genes were established by homology-based cloning (Nomura et al. 1998; Wu et al. 1998a; Veldhuisen et al. 1999).
Interestingly, TRPP family genes are conserved in vertebrates, invertebrates and yeast, e.g. pkd2 in Danio rerio, amo in Drosophila melanogaster, Pkd-2 in Caenorhabditis elegans, suPC2 in sea urchin and pkd2 in Schizosaccharomyces pombe (Palmer et al. 2005; Barr and Sternberg 1999; Watnick et al. 2003; Gao et al. 2003; Neill et al. 2004; Sun et al. 2004). This ancient evolutionary origin has given rise to the hypothesis that TRPP ion channels might comprise the most archetypical TRP subfamily (Venkatachalam and Montell 2007).
PKD2 (GeneID 5,311) is located on chromosome 4q21–4q23 in positive orientation (Mochizuki et al. 1996). The gene is 70,110 base pairs (bp) long and comprises 15 exons (Hayashi et al. 1997). One mRNA transcript has been established (NM_000297). The TRPP2 protein consists of 968 amino acids (109,561 Da) (NP_000288).
PKD2L1 (GeneID 9,033) is located on chromosome 10q24 in negative orientation (Nomura et al. 1998; Wu et al. 1998a). The gene is 42,341 bp long and comprises 16 exons (Guo et al. 2000a, b). One mRNA transcript has been established (NM_016112), which is translated into TRPP3 (805 amino acids; 91,851 Da) (NP_057196).
PKD2L2 (GeneID 27,039) is located on chromosome 5q31 in positive orientation (Veldhuisen et al. 1999). The gene is 51,032 bp long and comprises 14 exons. One mRNA transcript has been established (NM_014386), which is translated into TRPP5 (613 amino acids; 72,365 Da) (NP_055201).
3 Expression of TRPP Ion Channels
The TRPP family genes are expressed ubiquitously in vertebrates. Large-scale transcriptome analysis detected TRPP mRNA in almost every human and mouse tissue (Su et al. 2004; Wu et al. 2009). The targeted examination of TRPP expression has confirmed and extended these results: PKD2 and PKD2L1 transcripts are indeed found in many foetal and adult tissues, including the heart, brain, lung, testis, ovary and kidney (Mochizuki et al. 1996; Nomura et al. 1998; Veldhuisen et al. 1999; Basora et al. 2002; Volk et al. 2003; Murakami et al. 2005; Ishimaru et al. 2006; Huang et al. 2006; Orts-Del’immagine et al. 2012). In contrast, PKD2L2 transcription appears to be mostly restricted to the testis (Veldhuisen et al. 1999; Guo et al. 2000b; Taft et al. 2002; Chen et al. 2008). Several TRPP splice variants have been described but their functional consequences remain elusive (Mochizuki et al. 1996; Nomura et al. 1998; Veldhuisen et al. 1999; Guo et al. 2000b).
Spatiotemporal control of PKD2 expression seems to be partially executed on a post-transcriptional level. Micro-RNAs modify gene expression by reducing protein translation through mRNA degradation or translational repression (He and Hannon 2004). The short non-coding microRNA group 17 (miR-17) and the RNA-binding protein bicaudal C (BICC1) apparently antagonise each other to fine-tune TRPP2 translation (Sun et al. 2010; Tran et al. 2010; Patel et al. 2013). miR-17 has been described to repress the expression of PKD2 post-transcriptionally (Sun et al. 2010; Tran et al. 2010; Patel et al. 2013). Kidney-specific transgenic over-expression of miR-17 produces kidney cysts in mice, while inactivation of miR-17 retards cyst growth in the heterologous mouse PKD model Kif3a −/− (Patel et al. 2013). BICC1, on the other hand, promotes PKD2 mRNA stability and translation efficiency while antagonising the repressive activity of miR-17 (Tran et al. 2010). Bicc1 −/− animals develop a renal cyst phenotype reminiscent of PKD (Tran et al. 2010). However, future experiments will have to address whether the observed miR-17 and Bicc1 −/− cyst phenotypes are exclusively linked to decreased TRPP2 protein levels, because miR-17 targets a plethora of genes some of which are known cyst genes (Tran et al. 2010; Cloonan et al. 2008).
In C. elegans and D. melanogaster, PKD2 expression is highly restricted to ciliated cells, predominantly male-specific sensory neurons and spermatozoa, respectively (Barr and Sternberg 1999; Watnick et al. 2003; Gao et al. 2003; Yang et al. 2011; Köttgen et al. 2011). A temporal control of pkd2 expression has been proposed in the fission yeast, S. pombe, where pkd2 mRNA levels increase following damage to the cell wall (Palmer et al. 2005).
It is intriguing to speculate that the expansion of TRPP gene expression (and therefore most likely TRPP protein function) is evolutionary coupled to the increase in ciliated cell types. There are very few ciliated cells expressing TRPP genes in invertebrates and almost ubiquitous ciliation and TRPP expression in humans.
4 The TRPP Proteins
The nomenclature of TRPP ion channels has been somewhat inconsistent. Initial publications grouped both ADPKD proteins into the polycystin family. The founding member of the TRPP subfamily, polycystin-2, was later classified as TRPP2. The designation TRPP1 has caused some confusion, as it has been used for both polycystin-1 and polycystin-2. We strongly advocate the following TRP nomenclature: 1) bona fide TRPP ion channels and 2) receptor-like polycystin-1 family proteins (Tables 1 and 2). Because of ambiguity TRPP1 and TRPP4 should not be used.
TRPP2, TRPP3 and TRPP5 are the three Ca2+-permeable non-selective cation TRPP ion channel proteins (Fig. 1) (Clapham 2003; Nilius and Owsianik 2011). They share a high degree of amino acid sequence identity and similarity. ClustalW sequence alignment of TRPP3 and TRPP2 shows 48 % identity and 70 % sequence similarity (Larkin et al. 2007). TRPP5 is only slightly more distant from TRPP2 with 45 % identity and 68 % similarity (Larkin et al. 2007).
Unfortunately, to date no high-resolution crystal structure is available for any full-length TRP channel (Li et al. 2011). Current TRPP protein models are therefore based on less accurate experimental methods and predictions. Studies on the architecture of TRP channels in general yielded strong evidence that these channels function as tetramers (Jahnel et al. 2001; Kedei et al. 2001; Moiseenkova-Bell et al. 2008). Monomeric TRP channel subunits are integral membrane proteins with six predicted transmembrane helices (S1–S6), framing a pore-forming loop between S5 and S6 and cytosolic amino- and carboxy-termini of varying sizes (Venkatachalam and Montell 2007; Clapham 2003; Nilius and Owsianik 2011; Li et al. 2011). The prominent feature of TRPP ion channels is a large extracellular loop between S1 and S2, consisting of 245 amino acids in TRPP2, 224 in TRPP3 and 225 in TRPP5. While the transmembrane helices are highly conserved in the TRPP family, major deletions have occurred in the protein termini. Basically, TRPP3 is missing approximately 100 amino acids of the TRPP2 amino-terminus and TRRP5 has lost both sections of the TRPP2 amino- and carboxy-terminus. TRPP sequence divergence in mammals, e.g. amino acid substitution, is mainly observed in the loop regions between the transmembrane helices (Ye et al. 2009).
TRPP2 has six predicted transmembrane domains and their orientation has recently been validated by transient expression of truncated TRPP2 mutants and selective membrane permeabilisation (Hoffmeister et al. 2011a). In line with expectations, both the amino- and carboxy-terminus have been found to protrude into the cytoplasm (Hoffmeister et al. 2011a). The carboxy-terminal region of TRPP2 has attracted particular research interest. It comprises several sequence elements required for proper TRPP2 function, including a Ca2+-binding EF hand (TRPP2754–781), two coiled-coil domains (CC1: TRPP2769–796/CC2: TRPP2835–873), an endoplasmic reticulum retention motif (TRPP2787–820) and an acidic amino acid cluster (TRPP2810–821) (Fig. 1) (Cai et al. 1999; Hanaoka et al. 2000; Köttgen et al. 2005; Ćelić et al. 2008, 2012; Yu et al. 2009; Petri et al. 2010; Giamarchi et al. 2010). The EF hand has been implicated in ion channel gating and the acidic cluster in protein trafficking, whereas the two coiled-coil domains have been demonstrated to be required for homo- and heteromerisation of TRPP2 subunits (Köttgen et al. 2005; Ćelić et al. 2008, 2012; Yu et al. 2009; Petri et al. 2010; Giamarchi et al. 2010). Structural analysis of recombinant TRPP2 carboxy-terminal fragments and specific amino acid substitutions in full-length TRPP2 have yielded some insight into the molecular mechanisms controlling TRPP2 channel assembly. The formation of functional ion channel homomers or alternatively heteromers seems to be a controlled multistep process which is initiated by the assembly of TRPP2 homomers (Yu et al. 2009; Giamarchi et al. 2010; Feng et al. 2008, 2011). An amino-terminal oligomerisation domain (TRPP2199–207), a cysteine632-dependent disulphide bond and CC2 apparently stabilise TRPP2 homomers, which are the basis for CC1-mediated interactions to form active ion channels (Yu et al. 2009; Giamarchi et al. 2010; Feng et al. 2008, 2011; Qian et al. 1997; Tsiokas et al. 1997). However, some controversies concerning the sequence of events and the respective TRPP2 multimerisation state remain unsettled (Yu et al. 2009; Giamarchi et al. 2010; Kobori et al. 2009; Molland et al. 2010). Similar data have been reported for TRPP3 (Molland et al. 1824, 2010; Yu et al. 2012). The crystal structure of TRPP3561–805 fragments is stabilised by trimerisation (Molland et al. 1824; Yu et al. 2012). Taken together, these data raise the question whether TRPP proteins form trimers or tetramers, like other TRP ion channels. It is rather difficult to extrapolate from the data provided by the crystal structure of TRPP carboxy-terminal fragments to the full-length ion channel configuration. Further data are required to clarify this issue.
In eukaryotic cells, an additional level of information content is added to protein structures by co- and post-translational modifications. Most frequent are glycosylation and phosphorylation, which are essential for protein processing and function (Tarrant and Cole 2009; Moremen et al. 2012). TRPP2 has been demonstrated to be glycosylated, but a detailed mapping and characterisation of implicated amino acid residues is lacking (Cai et al. 1999; Newby et al. 2002). A large number of phosphorylation sites in TRPP2 have been predicted and identified (Cai et al. 2004; Olsen et al. 2006; Streets et al. 2006, 2010, 2013; Hoffert et al. 2006; Molina et al. 2007; Zanivan et al. 2008; Huttlin et al. 2010; Hsu et al. 2011; Plotnikova et al. 2011). Serine76, serine801, serine812 and serine829 have been studied in more detail (Köttgen et al. 2005; Cai et al. 2004; Streets et al. 2006, 2010, 2013; Plotnikova et al. 2011; Li et al. 2005a; Fu et al. 2008). Glycogen synthase kinase 3 (GSK3) was shown to phosphorylate serine76, thereby promoting redistribution of plasma membrane TRPP2 to intracellular compartments (Streets et al. 2006). Phosphorylation of serine801 appears to be protein kinase D-dependent and increased by epidermal growth factor stimulation (Streets et al. 2010). Phosphorylation of serine812 by casein kinase 2 (CK2) contributes to the regulation of TRPP2 trafficking and ion channel activity (Köttgen et al. 2005; Cai et al. 2004; Fu et al. 2008). Serine829 is phosphorylated by either aurora A or protein kinase A (PKA) and has been reported to modulate ion channel function (Plotnikova et al. 2011; Streets et al. 2013). It is important to note, however, that the functional importance of these TRPP2 modifications is still difficult to evaluate as over-expressed TRPP2 is trapped in the endoplasmic reticulum, impeding the electrophysiological analysis at the plasma membrane (also see Sect. 6).
5 TRPP Interacting Proteins
TRPP ion channels are embedded in a complex network of protein–protein interactions. After translation, their localisation, function and activity are shaped by a multitude of associated proteins (http://trpchannel.org/families/TRPP) (Tables 3 and 4). Like many TRP proteins, TRPP subunits assemble into functional ion channel homomers, but have also been found to form heteromeric complexes. Their intimate relationship with polycystin-1 family proteins adds yet another layer of complexity to these fascinating proteins. TRPP ion channels and polycystin-1 family proteins constitute versatile receptor–channel modules that use Ca2+ as second messenger (Fig. 2). They have been implicated in many signalling cascades, including establishment of body asymmetry and coordination of three-dimensional tissue organisation (Hofherr and Köttgen 2011; Hofherr 2012).
5.1 The TRPP–Polycystin-1 Signalling Module
PKD1 was the first ADPKD gene to be identified by linkage analysis (Reeders et al. 1985; European Polycystic Kidney Disease Consortium 1994; International Polycystic Kidney Disease Consortium 1995). Mutations in either PKD1 or PKD2 cause virtually indistinguishable disease manifestations in humans (Longo and Harrison 2012). PKD1 is the founding member of the polycystin-1 family, which consists of five large membrane-bound receptor proteins: PKD1, PKD1-like 1 (PKD1L1), PKD1-like 2 (PKD1L2), PKD1-like 3 (PKD1L3) and PKD and sperm receptor for egg jelly homolog-like (PKDREJ) (Reeders et al. 1985; European Polycystic Kidney Disease Consortium 1994; International Polycystic Kidney Disease Consortium 1995; Yuasa et al. 2002; Li et al. 2003a; Sutton et al. 2006). Their signature feature is the tripartite combination of a G-protein-coupled receptor proteolytic site (GPS), the receptor for egg jelly (REJ) domain and the lipoxygenase homology/polycystin, lipoxygenase, atoxin (LH2/PLAT) domain that is separated from the previous two by a transmembrane helix (Qian and Noben-Trauth 2005).
PKD1 (GeneID 5,310) is located on chromosome 16q13.3 in negative orientation. The gene is 47,189 bp long and comprises 92 exons (Reeders et al. 1985; European Polycystic Kidney Disease Consortium 1994; International Polycystic Kidney Disease Consortium 1995). Two mRNA transcripts have been established (NM_001009944, NM_000296), which are translated into polycystin-1 isoform 1 and polycystin-1 isoform 2 (4,303 and 4,292 amino acids; 462,529 and 461,365 Da, respectively) (NP_001009944, NP_000287). In addition, six PKD1 pseudo-genes (PKD1P1–PKD1P6) have been identified in 16q13.11–16q13.13 (GeneIDs: 339,044/283,955/339,039/353,512/348,156/353,511).
PKD1L1 (GeneID 168,507) is located on chromosome 7q12.3 in negative orientation (Yuasa et al. 2002). The gene is 173,748 bp long and comprises 57 exons. One mRNA transcript has been established (NM_138295), which is translated into PKD1L1 (NP_612152), a 315,305 Da protein comprising 2,849 amino acids.
PKD1L2 (GeneID 114,780) is located on chromosome 16q23.2 in negative orientation. The gene is 119,492 bp long and comprises 61 exons (Li et al. 2003a). Two mRNA transcripts have been established (NM_052892, NM_001076780), which are translated into PKD1L2 isoform A and C (2,459 and 991 amino acids; 272,384 and 107,813 Da, respectively) (NP_443124, NP_001070248).
PKD1L3 (GeneID 342,372) is located on chromosome 16q22.3 in negative orientation (Li et al. 2003a). The gene is 70,984 bp long and comprises 30 exons. One mRNA transcript has been established (XM_001133467), which is translated into PKD1L3 (XP_001133467), a 195,894 Da protein (1,731 amino acids).
PKDREJ (GeneID 10,343) is located on chromosome 22q13.31 in negative orientation. The single exon gene is 7,660 bp long (Sutton et al. 2006). One mRNA transcript has been established (NM_006071). The PKDREJ protein consists of 2,253 amino acids (255,449 Da) (NP_006062).
The interaction of TRPP2 and polycystin-1 has been extensively studied at all levels of complexity (Fig. 2). Loss of either one of these proteins causes severe life-threatening cystic kidney disease (Mochizuki et al. 1996; Reeders et al. 1985; European Polycystic Kidney Disease Consortium 1994; International Polycystic Kidney Disease Consortium 1995). Together they are a prerequisite for the coordination of three-dimensional renal tubular organisation. The TRPP2–PKD1L1 signalling module on the other hand is required for the embryonic establishment of a left–right axis, i.e. the asymmetric arrangement of unpaired organs (also see Sect. 7) (Hofherr 2012; Field et al. 2011; Kamura et al. 2011).
TRPP5 and PKDREJ are abundantly expressed in the male germline, but no physical interaction has been observed (Veldhuisen et al. 1999; Sutton et al. 2006; Hughes et al. 1999).
5.2 TRP–TRPP Heteromers
TRPP2 can interact with several TRP channels, including TRPC1, TRPC3, TRPC4, TRPC5, TRPC7 and TRPV4 (Kobori et al. 2009; Sutton et al. 2006; Tsiokas et al. 1999; Köttgen et al. 2008; Du et al. 2008; Miyagi et al. 2009; Stewart et al. 2010). The respective ion channel function seems to be modulated via the TRP subunit composition, adapting the functional properties of TRPP2 to tissue-specific roles including mechano- and chemosensation (Köttgen et al. 2008).
5.3 TRPP and the Cellular Cytoskeleton
The dynamic coordination of cellular structures is a major function of the cytoskeleton. It is composed of three main components: 1) actin filaments; 2) intermediate filaments; and 3) microtubules (Wickstead and Gull 2011). Actin filaments provide the cell’s scaffold. TRPP2 was shown to be attached to actin by direct and indirect means, e.g. by tropomyosin-1 and α-actinin or CD2AP and HAX1, respectively (Li et al. 2003b, c, 2005a; Lehtonen et al. 2000; Gallagher et al. 2000). To guide proper cytoskeletal development, actin filaments can be cross-linked to bundles by filamin proteins (Zhou et al. 2010; Ohta et al. 2006). Filamin A and TRPP2 were reported to regulate pressure sensing in mouse vascular smooth muscle cells, i.e. fine-tuning stretch-activated channels to adapt the vascular myogenic response (Sharif-Naeini et al. 2009). Microtubules, on the other hand, make up the internal structure of cilia and provide platforms for intracellular transport (Rosenbaum and Witman 2002). TRPP2 was shown to bind and co-localise with two motor proteins required for intra-flagellar transport in primary cilia, KIF3A and KIF3B (Li et al. 2006; Wu et al. 2006). At microtubule-organising centres, TRPP2 interactions with pericentrin and mammalian diaphanous 1 protein (mDia1) apparently modulate the intracellular Ca2+ homeostasis (Jurczyk et al. 2004; Rundle et al. 2004).
5.4 TRPP Protein Trafficking
The cellular distribution of TRPP2 is determined by the subsequent interaction with various trafficking proteins. Endoplasmic reticulum, plasma membrane and primary cilia are the most prominent TRPP2 compartments (Witzgall 2005; Cai et al. 1999; Koulen et al. 2002; Pazour et al. 2002; Yoder et al. 2002).
The two proteins implicated in autosomal dominant polycystic liver disease (ADPLD), Sec63p and glucosidase 2 subunit β, function as part of the endoplasmic reticulum translocation, folding and quality control machinery (Drenth et al. 2003; Davila et al. 2004). Their physiological interaction with polycystin-1 and TRPP2 is necessary for module processing. Impairment of either ADPLD gene causes insufficient functional expression of the polycystin-1–TRPP2 receptor–channel complex resulting in cystic disease (Fedeles et al. 2011).
Post-endoplasmic reticulum sorting of TRPP2 seems to be controlled by an intricate interplay of intrinsic TRPP2 amino acid trafficking motifs and their ligands. Multiple motifs have been described including an endoplasmic reticulum retention motif (TRPP2787–820), an acidic cluster comprising the serine812 phosphorylation site (TRPP2810–821), and an amino-terminal ciliary import signal, RVxP (R, arginine; V, valine; x, any amino acid; P, proline) (TRPP26–9) (Cai et al. 1999; Hanaoka et al. 2000; Köttgen et al. 2005; Geng et al. 2006). Phosphorylation of serine812 in TRPP2 by casein kinase 2 (CK2) regulates the binding of phosphofurin acidic cluster sorting protein 1 (PACS-1) or PACS-2 and routes TRPP2 to the endoplasmic reticulum, Golgi complex or plasma membrane compartments (Köttgen et al. 2005). In addition, PIGEA-14 promotes the endoplasmic reticulum to trans-Golgi complex transport of TRPP2 by way of a carboxy-terminal interaction (Hidaka et al. 2004). Interestingly, germline inactivation of PIGEA-14 causes defective airway kinocilia (Voronina et al. 2009). Ciliary sorting of TRPP2 was proposed to be dependent on Rab8a expression (Hoffmeister et al. 2011b). Interestingly, the latter study showed that TRPP2 takes different routes to the somatic and ciliary plasma membrane. The transport of TRPP2 to the ciliary and to the somatic plasma membrane compartments originates in a COPII-dependent fashion at the endoplasmic reticulum. TRPP2 reaches the cis-Golgi complex in either case, but trafficking to the somatic plasma membrane goes through the Golgi complex, whereas transport vesicles to the cilium leave the Golgi complex at the cis compartment (Hoffmeister et al. 2011b).
5.5 TRPP and A-Kinase Anchoring Protein (AKAP) Complex
Dysregulation of cyclic adenosine monophosphate (cAMP) signalling has been implicated in the pathogenesis of cystic kidney diseases, i.e. promoting fluid secretion and cell proliferation (Hanaoka and Guggino 2000; Belibi et al. 2004; Torres et al. 2012). The molecular mechanisms leading to increased cAMP production in cyst epithelia are still incompletely understood. Recently, it has been shown that TRPP2 and phosphodiesterase 4C are components of a ciliary A-kinase anchoring protein (AKAP) complex that is disrupted in cystic kidney diseases (Choi et al. 2011). AKAP complexes organise cellular signal transduction by compartmentalising second messenger-regulated enzymes (Wong and Scott 2004; Dessauer 2009). In AKAP complexes, TRPP2 was reported to bind adenylyl cyclase 5/6 (AC5/6), a Ca2+-inhibitable enzyme, in primary cilia (Choi et al. 2011). It has therefore been suggested that loss of TRPP2 inhibitory activity may cause increased AC5/6-mediated cAMP production (Choi et al. 2011).
6 Biophysical Description of the Channel Function, Permeation and Gating
TRPP ion channels have been shown to function as Ca2+-permeable non-selective cation channels.
6.1 TRPP3
TRPP3 was the first member of the TRPP family to be identified as a cation channel (Chen et al. 1999). Expression of TRPP3 in Xenopus laevis oocytes gave rise to constitutively active, Ca2+-permeable non-selective cation channels with a high single-channel conductance of 137 pS. High intracellular Ca2+ increased channel activity, whereas low extracellular pH decreased conductance (Chen et al. 1999; Shimizu et al. 2009). More recently, TRPP3 activity was found to be voltage dependent and increased upon cell swelling and by alkalinisation (Shimizu et al. 2009, 2011). There have been conflicting results as to whether TRPP3 channel function requires co-expression of PKD1L3 and whether this complex is an acid-sensing channel complex required for sour taste transduction (Yu et al. 2012; Chen et al. 1999; Shimizu et al. 2009; Chaudhari and Roper 2010).
6.2 TRPP5
Limited information is available concerning TRPP5 channel function. No spontaneous channel activity has been observed upon over-expression of TRPP5 in HEK293 cells. In outside-out patches, however, these cells exhibited a channel with a single 25 pS conductance state (Sutton et al. 2006).
6.3 TRPP2
After cloning of PKD2 in 1996 and description of its channel-like topology (Mochizuki et al. 1996), it took four more years until the first report of the channel function was published (Hanaoka et al. 2000). The reason for the difficulty in measuring TRPP2 channel function at the plasma membrane was explained by the identification of a carboxy-terminal retention motif (TRPP2787–820) causing exclusive endoplasmic reticulum localisation of over-expressed TRPP2 (Cai et al. 1999). Carboxy-terminal truncations of TRPP2 deleting the retention motif traffic to the plasma membrane; channel activity has been reported for these truncation mutants (Chen et al. 2001). The cellular localisation and site of action of full-length TRPP2 has been discussed controversially: some groups favour the endoplasmic reticulum as the physiological site of action of TRPP2, others the plasma membrane (Cantiello 2004; Witzgall 2005; Hanaoka et al. 2000; Köttgen et al. 2005; Koulen et al. 2002). The first report on TRPP2 channel function provided evidence that polycystin-1 and TRPP2 interact to form a functional heteromeric complex (Hanaoka et al. 2000). This study reported that TRPP2 alone did not form functional channels, but co-expression of polycystin-1 and TRPP2 promoted the translocation of TRPP2 to the plasma membrane and produced Ca2+-permeable non-selective cation currents (Hanaoka et al. 2000). This finding was later confirmed in neurons where over-expressed polycystin-1 and TRPP2 formed a functional receptor–channel complex (Delmas et al. 2004b).
The functional reconstitution of the polycystin-1/TRPP2 complex in heterologous expression systems could be very useful to screen for ligands and specific inhibitors and to study activation mechanisms as well as regulation of the receptor–channel complex. Considering the fact that functional reconstitution of the polycystin-1/TRPP2 complex in over-expression systems might help to address several fundamental questions in the field, surprisingly little has been published in this area since 2004.
After initial studies reporting TRPP2 whole-cell currents, several single-channel studies characterised the channel properties in more detail (Vassilev et al. 2001; González-Perrett et al. 2001, 2002). The specific biophysical properties and the channel function of TRPP2 are reviewed elsewhere (Delmas et al. 2004a; Cantiello 2004). In brief, TRPP2 has been reported to display a single-channel conductance of 100–200 pS and a spontaneous open probability ranging from 0.2 to 0.4. TRPP2 displays non-selective cation channel activity, with slight preference for divalent cations (Vassilev et al. 2001; González-Perrett et al. 2001; Luo et al. 2003). The properties of endoplasmic reticulum resident TRPP2 were studied at single-channel resolution using reconstitution of microsomes in lipid bilayers (Koulen et al. 2002). These studies confirmed that microsomal TRPP2 functions as a Ca2+-permeable non-selective cation channel, but also showed some biophysical properties that differed from those reported for TRPP2 in other studies (Koulen et al. 2002). One interesting aspect of these studies is the regulation of TRPP2 by Ca2+ via a carboxy-terminal EF hand in the channel protein (Koulen et al. 2002). The EF-hand Ca2+-binding motifs of TRPP2 and TRPP3 may be involved in the observed intracellular Ca2+-dependent activation of the channel (Koulen et al. 2002; Chen et al. 1999). This is supported by the observation that TRPP2742X, a naturally occurring pathogenic mutant lacking the EF hand, does not display Ca2+ activation (Chen et al. 2001). Furthermore phosphorylation of serine812 of TRPP2 regulates the Ca2+-dependent activation of the channel (Cai et al. 2004). Several recent studies investigated the structural and functional properties of the helix-loop-helix structural EF-hand motif in TRPP2 in more detail (Ćelić et al. 2008, 2012; Petri et al. 2010). Structural analysis demonstrated discrete conformational transitions and oligomerisation state changes upon the addition of Ca2+ to recombinant TRPP2 fragments (TRPP2720–797 [EF hand] and TRPP2704–968 [TRPP2 carboxy-terminus]), and the authors propose that the EF hand is required for channel gating (Ćelić et al. 2012).
In summary, the channel function of TRPP channels (in particular TRPP2) has been studied quite extensively but important questions remain. In the case of TRPP2, this is mostly due to the fact that functional reconstitution of this channel at the plasma membrane has proven to be difficult. There has been a report of TRPP2 channel activity at the ciliary membrane, but these recordings are technically challenging (Raychowdhury et al. 2005). The identification of factors that allow the robust reconstitution of the TRPP2 channel complex at the plasma membrane in over-expression systems would undoubtedly help to advance the electrophysiological analysis of this important disease-associated ion channel. The identification of physiological activation mechanisms, regulatory factors and specific inhibitors of TRPP2 will be critical to study channel function under more physiological conditions, i.e. in the native tissue.
7 Physiological Functions of TRPP Channels in Native Cells, Organs, and Organ Systems
The physiological importance of TRPP channels and polycystin-1 family proteins becomes evident in light of severe phenotypes observed upon loss of function in humans and model organisms. The founding members of the polycystin family, TRPP2 and polycystin-1, are a prime example of how studying human disease genes can provide insights into fundamental biological mechanisms using a so-called “reverse translational” approach (from bedside to bench). In fact, studying polycystic kidney disease genes has provided considerable insights into processes like tubular morphogenesis, left–right patterning and signalling through primary cilia.
Homozygous null alleles of PKD1 or PKD2 are embryonic lethal in mice and men (also see Sect. 8) (Lu et al. 1997; Wu et al. 1998b, 2000; Paterson et al. 2002; Piontek et al. 2004, 2007; Pennekamp et al. 2002; Garcia-Gonzalez et al. 2010). Loss of function of either gene causes cyst formation in the kidneys, liver and pancreas. Thus, one physiological function of these proteins must be in regulating tubular morphogenesis and maintenance of tubular structures. Both genes have a role in vascular integrity, since loss of function causes cardiovascular phenotypes ranging from cardiac valve defects to aneurysms and abnormal vascular permeability in knockout mice (Garcia-Gonzalez et al. 2010; Kim et al. 2000; Boulter et al. 2001). The embryonic lethality in PKD knockout mice appears to be caused by vascular defects in the placenta (Garcia-Gonzalez et al. 2010). In addition, TRPP2 is essential for the establishment of left–right asymmetry in vertebrates, as loss of TRPP2 function results in heterotaxy, i.e. the abnormal left–right distribution of visceral organs, in zebrafish and mice (Pennekamp et al. 2002; Bisgrove et al. 2005; Schottenfeld et al. 2007). Extensive efforts have been devoted to investigate the molecular and cellular mechanisms, which are the basis for these physiological functions. It is assumed that polycystins function as signalling proteins, but there is no consensus yet about the precise role of the polycystins in cellular signal transduction (Köttgen 2007; Torres and Harris 2009). Importantly, neither the activation mechanisms nor the downstream components of the enigmatic polycystin signalling pathway are known. One intriguing concept that has emerged from studying polycystin function is the importance of primary cilia in cellular signal transduction and organ development (Hildebrandt and Otto 2005).
7.1 The Ciliary Connection
The primary cilium, once considered an evolutionary relic without apparent function, has recently stepped into the spotlight, as a flood of data indicates that cilia have crucial roles in vertebrate development and human genetic diseases (Hildebrandt et al. 2011; Goetz and Anderson 2010). Research on polycystic kidney disease genes has significantly spurred this Cinderella-like transformation. Cilia are antenna-like structure emanating from the surface of virtually every cell in mammals. Cilia contain an axoneme of nine microtubule doublets surrounded by a ciliary membrane. There is mounting evidence that cilia function as a nexus for signalling pathways, translating extracellular cues into cellular signal transduction events (Goetz and Anderson 2010). Orthologues of polycystin-1 and TRPP2 were first localised on ciliated endings of sensory neurons in C. elegans and later in cilia of mammalian cells (Barr and Sternberg 1999; Pazour et al. 2002; Yoder et al. 2002). Meanwhile, a plethora of proteins involved in cystic kidney disease have been detected in primary cilia. Furthermore, genetic ablation of cilia in animal models leads to cyst formation (Hildebrandt et al. 2011; Yoder et al. 1996; Pazour et al. 2000; Lin et al. 2003). It is now generally accepted that cilia play an important role in polycystin function, but the precise mechanisms of polycystins in ciliary signalling remain unresolved. In addition to primary cilia, TRPP2 has been proposed to function in other cellular compartments including the lateral membrane of epithelial cells and the endoplasmic reticulum (Köttgen 2007; Koulen et al. 2002; Scheffers et al. 2002; Li et al. 2005b; Wegierski et al. 2009; Sammels et al. 2010; Mekahli et al. 2012). Despite the apparent importance of primary cilia, other compartment-specific functions of polycystins may also contribute to the diverse roles of these proteins in different organs.
7.2 Activation Mechanisms
The activation mechanism of the polycystin-1/TRPP2 receptor–channel complex is an important open question in the field. Cilia have been shown to function as mechanosensors (Praetorius and Spring 2005). Bending of cilia by tubular fluid triggers cytosolic Ca2+ signals (Praetorius and Spring 2001). Polycystin-1 and TRPP2 are required for flow-induced Ca2+ signals in renal tubular epithelial cells (Nauli et al. 2003; Boehlke et al. 2010). This finding suggested that the mechanical activation of the polycystin complex could be the critical signal regulating tubular morphogenesis, and it has been proposed that the loss of flow-mediated Ca2+ signalling causes cyst formation (Nauli et al. 2003; Nauli and Zhou 2004). While the hypothesis that mechanical signals in the tubule lumen convey spatial information to polarised epithelial cells is intriguing, there is also evidence suggesting that flow-mediated Ca2+ signalling may not be required for the regulation of tubular geometry (Köttgen et al. 2008; Kotsis et al. 2013). An alternative hypothesis for the activation mechanism of the polycystin complex may involve yet-to-be identified ligands. To date, there is some indirect evidence supporting such a hypothesis (Barr and Sternberg 1999; Köttgen et al. 2011; Delmas et al. 2004b). Unfortunately, the identification of ligands for orphan receptors is notoriously challenging. But the prospect to deorphanise the polycystin-1/TRPP2 receptor–channel complex holds great promise to gain a better understanding of polycystin signalling and may, in our view, justify concerted efforts to screen for ligands using biochemical, physiological and genetic approaches.
Another interesting hypothesis concerning putative activation mechanisms of polycystins comes from the fact that polycystin-1 bears striking similarities to the so-called adhesion class G-protein-coupled receptors (adhesion GPCRs) (Qian et al. 2002; Wei et al. 2007; Langenhan et al. 2013). The adhesion GPCRs are a unique protein family with more than 30 members, which are involved in multiple signalling pathways. A common feature of these receptors is a GPCR autoproteolysis-inducing (GAIN) domain and cleavage of the extracellular amino-terminus at a G-protein-receptor-coupled proteolytic site (GPS) (Langenhan et al. 2013). It has been shown that the cleaved amino-terminal fragment can bind to the membrane-anchored carboxy-terminal fragment of adhesion GPCRs, where it could act as an endogenous ligand or play a role in binding ligands (Langenhan et al. 2013). Polycystin-1 has a GAIN domain and it was shown that the huge extracellular amino-terminus of polycystin-1 is cleaved autoproteolytically at the GPS motif (Qian et al. 2002; Wei et al. 2007). The cleaved amino-terminus remains tethered to the membrane-bound carboxy-terminal rest of the protein in a covalent manner (Qian et al. 2002). In addition, it was shown that knock-in mice with a non-cleavable GPS site in polycystin-1 are viable but show a rapid onset of cystic kidney disease developing mainly from the distal parts of the nephron (Yu et al. 2007). Further investigation revealed that two endogenous forms of polycystin-1 coexist in wild-type mice: a small amount of uncleaved full-length PC-1 and cleaved polycystin-1, which is more abundant. These studies provide compelling evidence that cleavage is not essential for embryonic development but required for maintenance of the integrity of the distal nephron segments (Yu et al. 2007). In summary, it is intriguing to speculate that the amino-terminal cleavage product of polycystin-1 could play a ligand-like or a ligand-binding role in the activation and regulation of the polycystin-1/TRPP2 channel complex akin to models proposed for adhesion GPCRs (Langenhan et al. 2013).
7.3 Left–Right Asymmetry
Another interesting connection between cilia and polycystins came from the surprising observation that TRPP2 is required for left–right axis determination in vertebrates (Pennekamp et al. 2002). Loss of TRPP2 has been shown to cause heterotaxy in mice and zebrafish, as well as in three patients with ADPKD (Pennekamp et al. 2002; Bisgrove et al. 2005; Schottenfeld et al. 2007; Bataille et al. 2011). The asymmetric placement of internal organs in vertebrates is established by the action of cilia in a pit-like structure called the embryonic node (McGrath et al. 2003; Hirokawa et al. 2006). Rotating cilia generate unidirectional fluid flow across the node from left to right. TRPP2 is required to sense the fluid flow in immotile cilia of perinodal crown cells (Yoshiba et al. 2012). It is not known whether this process involves chemo- or mechanosensation, or both (Norris and Grimes 2012). Interestingly, loss of PKD1, which gives rise to similar phenotypes like PKD2 in most organs, does not cause heterotaxy. Thus, TRPP2 acts independently of polycystin-1 in the establishment of left–right asymmetry. Recently, it was shown that TRPP2 forms a complex with PKD1L1 in the node to form a sensory protein complex required for left–right patterning (Field et al. 2011; Kamura et al. 2011; Vogel et al. 2010). This finding provides compelling evidence that polycystin-1 and TRPP family members can form distinct signalling modules that are adapted to tissue-specific functions (Hofherr 2012).
7.4 The Modular Concept
There is mounting evidence that TRPP channel subunits can form functional homomeric and heteromeric signalling modules, thereby expanding the diversity of organ-specific functions of these ion channels (also see Sect. 5). As mentioned above, there is strong biochemical and genetic data supporting a role for receptor–channel complexes comprised of different combinations of polycystin-1 family members with TRPP channel subunits. Besides the heavily studied complex of the founding members polycystin-1 and TRPP2 in polycystic kidney disease and the function of the PKD1L1/TRPP2 complex in left–right asymmetry, there is now also data suggesting that a heteromeric complex composed of PKD1L3 and TRPP3 might form an acid-activated complex involved in sour taste (Ishimaru et al. 2006; Huang et al. 2006; Lopezjimenez et al. 2006). Several research groups reported the circumscribed co-expression of PKD1L3 and TRPP3 in a specific subset of mouse taste receptor cells (Ishimaru et al. 2006; Huang et al. 2006; Lopezjimenez et al. 2006). These cells were found in taste buds and were reported to be distinct from the taste receptor cells mediating sweet, umami and bitter taste. Genetic ablation of the PKD1L3- and TRPP3-expressing cells in mice by targeted expression of attenuated diphtheria toxin leads to a complete loss of taste response to sour taste (Huang et al. 2006). The absence of an entire subpopulation of taste cells, however, does not necessarily establish the role of any given protein expressed by the missing cells. Support for the hypothesis that TRPP3 in association with PKD1L3 might form a candidate sour taste receptor came from heterologous over-expression systems. In heterologous expression systems TRPP3 appears to physically interact with PKD1L3 (Murakami et al. 2005; Ishimaru et al. 2006; Huang et al. 2006). HEK293T cells over-expressing PKD1L3 together with TRPP3 generated an inward current upon acid stimulation (Ishimaru et al. 2006). Yet, this channel is sensitive to extracellular pH rather than a drop in cytoplasmic pH, which is known to be the proximate stimulus for sour taste (Lyall et al. 2001; Huang et al. 2008). In addition, mice lacking PKD1L3 remain capable of detecting acid taste stimuli and Pkd2l1 −/− mice show only a partial reduction in sour taste transduction (Nelson et al. 2010; Horio et al. 2011). Since the PKD1L3/TRPP3 complex does not appear to be required for sour taste transduction, the search for the elusive sour taste receptor will continue.
The modular concept is not limited to TRPP channels and polycystin-1 family members. For example, it has been shown that TRPP2 interacts with other TRP channels like TRPC1 and TRPV4. TRPP2 and TRPV4 form a polymodal sensory channel complex that is involved in ciliary mechano- and thermosensation (Köttgen et al. 2008). A thermosensory role of TRPP channels appears to be evolutionarily conserved as TRPP channels have been shown to mediate cold sensation in D. melanogaster (Gallio et al. 2011).
In summary, TRPP channels and polycystin-1-like proteins have important physiological functions linking channel activity to fundamental developmental and sensory processes. We are beginning to understand some of the cellular mechanisms that explain the dramatic phenotypes observed upon loss of function of these proteins. Future studies will have to identify the molecular mechanisms translating channel activity into specific cellular signal transduction pathways controlling organ shape and patterning in vivo.
8 Lessons from Knockouts
The molecular analysis of TRPP2 and polycystin-1 is only the latest step of a long ADPKD research history. There has been an extensive collection of human loss of function data in ADPKD patients well before the molecular identity of the two ADPKD genes was known. However, because of the complex genetic situation in humans, animal model systems have been invaluable to elucidate the physiological function of TRPP and polycystin-1 family proteins. This is because ADPKD patients are heterozygous for the inherited PKD mutation in most of their cells with only very few cells that are homozygous due to somatic mutations (also see Sect. 9).
A number of constitutive and conditional mouse knockout models for PKD1 and PKD2 have been created (Wilson 2008). They faithfully recapitulate central aspects of the human phenotype (Lu et al. 1997; Wu et al. 1998b; Piontek et al. 2004, 2007; Pennekamp et al. 2002; Garcia-Gonzalez et al. 2010; Kim et al. 2000; Boulter et al. 2001). Constitutive Pkd1 −/− and Pkd2 −/− mice develop cystic kidneys, oedema as well as haemorrhage and typically die in utero ~15.5 days post-coitum (Lu et al. 1997; Wu et al. 1998b, 2000; Paterson et al. 2002; Pennekamp et al. 2002; Garcia-Gonzalez et al. 2010). Like in ADPKD patients, renal cysts originate from focal dilatations along all nephron segments, including occasional glomerular cysts (Wu et al. 1998b, 2000; Pennekamp et al. 2002; Baert 1978). Heterozygous PKD animals survive to adulthood; only Pkd1 +/− mice progressively develop scattered cystic disease at the age of 4–19 months, but the phenotype of heterozygous animals is rather mild and does not recapitulate the human disease (Boulter et al. 2001; Lu et al. 1999). Animals heterozygous for both Pkd1 and Pkd2 show a harsh progression of disease (Wu et al. 2002).
Tissue-specific and temporal conditional ablation of PKD genes was instrumental in uncovering additional functions of TRPP2 and polycystin-1 usually masked by embryonic lethality. Homozygous loss of PKD genes in mice paved the way to additional unexpected PKD-dependent phenotypes. One of these phenotypes was the impaired left–right asymmetry with randomisation of unilateral organ placement in Pkd2 and Pkd1l1 mutant mice, but not in Pkd1 −/− (also see Sect. 7) (Field et al. 2011; Kamura et al. 2011; Pennekamp et al. 2002). In addition, vascular fragility with haemorrhage and skeletal malformations were reported in Pkd1 and Pkd2 mutant mice (Kim et al. 2000; Boulter et al. 2001; Garcia-Gonzalez et al. 2010; Khonsari et al. 2013).
The time course of ADPKD in mice was elegantly probed using an inducible Pkd1 gene inactivation model (Piontek et al. 2004, 2007). Pkd1 deletion before day 13 post-coitum caused rapid progressive cyst formation in mice (Piontek et al. 2007), whereas Pkd1 inactivation after day 14 resulted in only mild PKD (Piontek et al. 2007). This notable embryonic switch in kidney development was corroborated by data from Kif3a and Ift88 mice, which present a similar response to timed gene ablation (Davenport et al. 2007).
Pkd2l1 −/− mice have no obvious phenotype, but show a 25–45 % reduced response to sour stimuli compared to wild-type (Horio et al. 2011). The suggested signalling module partner in sour tasting Pkd1l3, however, presents no taste phenotype upon gene inactivation (Nelson et al. 2010; Horio et al. 2011).
To date no Pkd2l2 −/− mouse phenotype has been published.
The evolutionary conservation of TRPP proteins facilitated the study of these proteins in Chlamydomonas reinhardtii, D. melanogaster and C. elegans (Barr and Sternberg 1999; Watnick et al. 2003; Gao et al. 2003; Köttgen et al. 2011; Hu and Barr 2005; Huang et al. 2007). In D. melanogaster, TRPP2 is a male-specific protein exclusively expressed at the distal tip of spermatozoa. It is required for male fertility, more precisely for the directed movement of spermatozoa in the female reproductive tract (Köttgen et al. 2011). Amo −/− (Pkd2 −/−) flies produce normal amounts of motile spermatozoa but are still infertile (Watnick et al. 2003; Gao et al. 2003; Köttgen et al. 2011). The TRPP homologues (Brivido 1–3) have been shown to be important for thermosensation in D. melanogaster (Gallio et al. 2011). Brivido mutant flies display a significant deficit in their avoidance to cold temperatures (Gallio et al. 2011). Pkd2 +/− mice exhibit impaired responses to warm temperatures, supporting an evolutionarily conserved role for TRPP channels in thermosensation (Köttgen et al. 2008). The C. elegans homologues of PKD1 and PKD2, Lov-1 and Pkd-2, are expressed in ciliated neuronal cells (Barr and Sternberg 1999; Hu and Barr 2005). The proteins are required for successful male mating behaviour (Barr and Sternberg 1999; Hu and Barr 2005). Studies of TRPP channels in invertebrate model organisms have added interesting functional insights. The restricted expression pattern of invertebrate TRPP channels in ciliated neurons and sperm has the advantage that null mutants are not lethal. This can be exploited to discover components in the TRPP signalling pathways using unbiased forward genetic screens.
9 Hereditary and Acquired Disease
Mutations in PKD1 or PKD2 cause ADPKD (#173900 and #613095 in Online Mendelian Inheritance of Man, http://www.ncbi.nlm.nih.gov/omim/) (Mochizuki et al. 1996; Reeders et al. 1985; European Polycystic Kidney Disease Consortium 1994; International Polycystic Kidney Disease Consortium 1995; Paterson and Pei 1998; Paul et al. 2014). ADPKD is the most common potentially lethal single-gene disorder in humans affecting one in 400–1,000 live births (U.S. Renal Data System 2012). The hallmark of ADPKD is the age-dependent massive enlargement of both kidneys, which is characterised by the formation of fluid-filled cysts. The defective three-dimensional tissue organisation in ADPKD begins in utero and is slowly progressive. Ultimately, approximately 50 % of affected individuals will develop end-stage renal disease (ESRD) by the sixth decade of life (Gabow et al. 1990; Hateboer et al. 1999; King et al. 2000; Fick-Brosnahan et al. 2002). In 2010, 26,993 United States citizens were suffering from kidney failure due to ADPKD; the incidence of ADPKD ESRD was 12,755 in the period of 2006–2010 (U.S. Renal Data System 2012). With no treatment options other than dialysis and kidney transplant, ESRD remains a severe illness with poor life expectancy. The five-year probability of survival among 2004 incident PKD ESRD patients was 38.8 % (Renal Data System 2011).
In general, ADPKD is slowly progressive. But the clinical course of the disease may be highly variable, ranging from neonatal death to adequate renal function into old age (Longo and Harrison 2012; Bergmann et al. 2008). The underlying sequence alterations in PKD1 and PKD2 are rather heterogeneous. Hundreds of unique mutations have been associated with ADPKD, but very limited information is available on genotype-phenotype correlation (The ADPKD Mutation Database, http://pkdb.mayo.edu) (Rossetti et al. 2002; Magistroni et al. 2003; Audrézet et al. 2012). The significant inter- and intra-familiar phenotypic variability points to the involvement of genetic and environmental modifiers to the ADPKD phenotype (Persu et al. 2004). Genetic determinants, including the level of polycystin-1 and TRPP2 together with the penetrance of pathogenic alleles, might modify the disorder’s slow progression over the course of decades (Fedeles et al. 2011; Rossetti et al. 2002). Environmental factors can influence the short-term progression of renal pathology, e.g. ADPKD cyst enlargement is significantly accelerated by acute kidney injury events (Takakura et al. 2009; Bastos et al. 2009; Prasad et al. 2009).
Although the clinical manifestations overlap completely between PKD1 and PKD2, there is a significant locus effect on renal pathology. On a population scale, PKD1 mutations cause earlier PKD with ESRD occurring at 54.3 years versus 74 years in PKD2 (Hateboer et al. 1999; Torra et al. 1996). In PKD2, gender correlates with phenotypic penetrance: men experience a faster worsening symptomatology than women, with ESRD at 68.1 years and 76 years, respectively (Hateboer et al. 1999; Magistroni et al. 2003). Whether a similar gender correlation holds true for PKD1 remains to be validated (Rossetti et al. 2002; Gabow et al. 1992; Harris et al. 2006).
Approximately 1,000,000 nephrons form a human kidney (Boron and Boulpaep 2009). Still, an ADPKD patient will develop only about a thousand cysts which will eventually disintegrate the kidney in a process associated with a decline in glomerular filtration and ESRD (Grantham 2008). The small quantity of overall cysts in relation to nephrons emphasises that only very few renal tubules undergo cystic transformation. This focal nature of ADPKD is consistent with a “two-hit” model, indicating that each cyst arises as a consequence of a distinct somatic mutation event (“second hit”) on the background of an inherited germline mutation (“first hit”) (Reeders 1992; Pei 2001). The acquired homozygous inactivation of PKD1 or PKD2 is a necessary pathogenic step leading to clonal expansion of cysts (Qian et al. 1996; Watnick et al. 1998; Menezes and Germino 2009). Thus, despite the dominant mode of inheritance, ADPKD is likely recessive at the cellular level. The “second hit” instant of time is of particular importance to cyst growth, i.e. inactivation of Pkd1 before postnatal day 13 provokes severely cystic kidneys within 3 weeks in mice, whereas inactivation at day 14 or later results in cysts only after 5 months (Piontek et al. 2007). Thus, it is likely that the kidney’s developmental stage defines the pathologic consequences of PKD1 deletion.
Genotypes homozygous and compound heterozygous for PKD1 or PKD2 have been reported to be embryonic lethal with PKD, cardiac failure and gross oedema (Wu et al. 2000; Paterson et al. 2002; Pennekamp et al. 2002; Boulter et al. 2001; Lu et al. 2001; Muto et al. 2002). Individuals heterozygous for both PKD1 and PKD2 mutations survive to adulthood but show an accelerated progression of disease (Wu et al. 2002; Pei et al. 2001).
Renal cysts are the most prominent manifestations of ADPKD, but a wide spectrum of mostly non life-threatening abnormalities accompany the disorder. Pain is a recurrent symptom in adult patients, often caused by cyst haemorrhage, cyst infection or kidney stones (Bajwa et al. 2001, 2004). Gross and microscopic haematuria are prevalent (Grantham et al. 2006). A major contributor to the decline in kidney function together with cardiovascular morbidity and mortality is arterial hypertension (Kelleher et al. 2004). Hepatic cysts are the primary extra-renal lesion (Bae et al. 2006). Cysts may also develop in the arachnoid membrane, pancreas and seminal tract (Danaci et al. 1998; Wijdicks et al. 2000). Cardiac and vascular manifestations include an increased incidence of valvular heart disease, coronary artery and intracranial aneurysms as well as chronic subdural haematoma (Wijdicks et al. 2000; Hossack et al. 1988; Schievink et al. 1995; Hadimeri et al. 1998; Lumiaho et al. 2001; Leung and Fan 2005).
In summary, ADPKD is a systemic disorder that represents a therapeutic challenge for clinicians across multiple disciplines. It is hoped that a better understanding of the pathogenic mechanisms will provide the basis for rational therapies of this devastating disease.
Conclusions
It has been exciting times since the identification of PKD1 and PKD2 as the genes mutated in ADPKD. Biological roles of the encoded proteins polycystin-1 and TRPP2 have been deduced from phenotypes in ADPKD patients, but recent insights from vertebrate and invertebrate model organisms have significantly expanded our understanding of the physiological functions of these proteins. The discovery of the central role of primary cilia and the modular assembly of TRPP channels and polycystin-1 family members are a strong foundation for future discoveries. The identification of upstream and downstream components in the enigmatic polycystin signalling pathway is one of the next important milestones. Clearly, we still have quite some work to do before we understand the molecular mechanisms of these proteins in biological processes like tubular morphogenesis and organ patterning.
References
Anyatonwu GI, Ehrlich BE (2004) Calcium signaling and polycystin-2. Biochem Biophys Res Commun 322:1364–1373
Anyatonwu GI, Estrada M, Tian X, Somlo S, Ehrlich BE (2007) Regulation of ryanodine receptor-dependent calcium signaling by polycystin-2. Proc Natl Acad Sci USA 104:6454–6459
Audrézet M, Cornec-Le Gall E, Chen J, Redon S, Quéré I, Creff J, Bénech C, Maestri S, Le Meur Y, Férec C (2012) Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients. Hum Mutat 33:1239–1250
Bae KT, Zhu F, Chapman AB, Torres VE, Grantham JJ, Guay-Woodford LM, Baumgarten DA, King BF, Wetzel LH, Kenney PJ, Brummer ME, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP (2006) Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort. Clin J Am Soc Nephrol 1:64–69
Baert L (1978) Hereditary polycystic kidney disease (adult form): a microdissection study of two cases at an early stage of the disease. Kidney Int 13:519–525
Bajwa ZH, Gupta S, Warfield CA, Steinman TI (2001) Pain management in polycystic kidney disease. Kidney Int 60:1631–1644
Bajwa ZH, Sial KA, Malik AB, Steinman TI (2004) Pain patterns in patients with polycystic kidney disease. Kidney Int 66:1561–1569
Barr MM, Sternberg PW (1999) A polycystic kidney-disease gene homologue required for male mating behaviour in C. elegans. Nature 401:386–389
Basora N, Nomura H, Berger UV, Stayner C, Guo L, Shen X, Zhou J (2002) Tissue and cellular localization of a novel polycystic kidney disease-like gene product, polycystin-L. J Am Soc Nephrol 13:293–301
Bastos AP, Piontek K, Silva AM, Martini D, Menezes LF, Fonseca JM, Fonseca II, Germino GG, Onuchic LF (2009) Pkd1 haploinsufficiency increases renal damage and induces microcyst formation. J Am Soc Nephrol 20:2389–2402
Bataille S, Demoulin N, Devuyst O, Audrézet M, Dahan K, Godin M, Fontès M, Pirson Y, Burtey S (2011) Association of PKD2 (polycystin 2) mutations with left-right laterality defects. Am J Kidney Dis 58:456–460
Belibi FA, Reif G, Wallace DP, Yamaguchi T, Olsen L, Li H, Helmkamp GM, Grantham JJ (2004) Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int 66:964–973
Bergmann C, Brüchle NO, Frank V, Rehder H, Zerres K (2008) Perinatal deaths in a family with autosomal dominant polycystic kidney disease and a PKD2 mutation. N Engl J Med 359:318–319
Bisgrove BW, Snarr BS, Emrazian A, Yost HJ (2005) Polaris and Polycystin-2 in dorsal forerunner cells and Kupffer’s vesicle are required for specification of the zebrafish left-right axis. Dev Biol 287:274–288
Boehlke C, Kotsis F, Patel V, Braeg S, Voelker H, Bredt S, Beyer T, Janusch H, Hamann C, Gödel M, Müller K, Herbst M, Hornung M, Doerken M, Köttgen M, Nitschke R, Igarashi P, Walz G, Kuehn EW (2010) Primary cilia regulate mTORC1 activity and cell size through Lkb1. Nat Cell Biol 12:1115–1122
Boron WF, Boulpaep EL (2009) Medical physiology. A cellular and molecular approach. Saunders/Elsevier, Philadelphia, PA
Boulter C, Mulroy S, Webb S, Fleming S, Brindle K, Sandford R (2001) Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene. Proc Natl Acad Sci USA 98:12174–12179
Bui-Xuan E, Li Q, Chen X, Boucher CA, Sandford R, Zhou J, Basora N (2006) More than colocalizing with polycystin-1, polycystin-L is in the centrosome. Am J Physiol Renal Physiol 291:F395–F406
Cai Y, Maeda Y, Cedzich A, Torres VE, Wu G, Hayashi T, Mochizuki T, Park JH, Witzgall R, Somlo S (1999) Identification and characterization of polycystin-2, the PKD2 gene product. J Biol Chem 274:28557–28565
Cai Y, Anyatonwu G, Okuhara D, Lee K, Yu Z, Onoe T, Mei C, Qian Q, Geng L, Wiztgall R, Ehrlich BE, Somlo S (2004) Calcium dependence of polycystin-2 channel activity is modulated by phosphorylation at Ser812. J Biol Chem 279:19987–19995
Cantiello HF (2004) Regulation of calcium signaling by polycystin-2. Am J Physiol Renal Physiol 286:F1012–F1029
Ćelić A, Petri ET, Demeler B, Ehrlich BE, Boggon TJ (2008) Domain mapping of the polycystin-2 C-terminal tail using de novo molecular modeling and biophysical analysis. J Biol Chem 283:28305–28312
Ćelić AS, Petri ET, Benbow J, Hodsdon ME, Ehrlich BE, Boggon TJ (2012) Calcium-induced conformational changes in C-terminal tail of polycystin-2 are necessary for channel gating. J Biol Chem 287:17232–17240
Chaudhari N, Roper SD (2010) The cell biology of taste. J Cell Biol 190:285–296
Chen XZ, Vassilev PM, Basora N, Peng JB, Nomura H, Segal Y, Brown EM, Reeders ST, Hediger MA, Zhou J (1999) Polycystin-L is a calcium-regulated cation channel permeable to calcium ions. Nature 401:383–386
Chen XZ, Segal Y, Basora N, Guo L, Peng JB, Babakhanlou H, Vassilev PM, Brown EM, Hediger MA, Zhou J (2001) Transport function of the naturally occurring pathogenic polycystin-2 mutant. Biochem Biophys Res Commun 282:1251–1256
Chen Y, Zhang Z, Lv X, Wang Y, Hu Z, Sun H, Tan R, Liu Y, Bian G, Xiao Y, Li Q, Yang Q, Ai J, Feng L, Yang Y, Wei Y, Zhou Q (2008) Expression of Pkd2l2 in testis is implicated in spermatogenesis. Biol Pharm Bull 31:1496–1500
Choi Y, Suzuki A, Hajarnis S, Ma Z, Chapin HC, Caplan MJ, Pontoglio M, Somlo S, Igarashi P (2011) Polycystin-2 and phosphodiesterase 4C are components of a ciliary A-kinase anchoring protein complex that is disrupted in cystic kidney diseases. Proc Natl Acad Sci USA 108:10679–10684
Clapham DE (2003) TRP channels as cellular sensors. Nature 426:517–524
Cloonan N, Brown MK, Steptoe AL, Wani S, Chan WL, Forrest ARR, Kolle G, Gabrielli B, Grimmond SM (2008) The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition. Genome Biol 9:R127
Danaci M, Akpolat T, Baştemir M, Sarikaya S, Akan H, Selçuk MB, Cengiz K (1998) The prevalence of seminal vesicle cysts in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 13:2825–2828
Davenport JR, Watts AJ, Roper VC, Croyle MJ, van Groen T, Wyss JM, Nagy TR, Kesterson RA, Yoder BK (2007) Disruption of intraflagellar transport in adult mice leads to obesity and slow-onset cystic kidney disease. Curr Biol 17:1586–1594
Davila S, Furu L, Gharavi AG, Tian X, Onoe T, Qian Q, Li A, Cai Y, Kamath PS, King BF, Azurmendi PJ, Tahvanainen P, Kääriäinen H, Höckerstedt K, Devuyst O, Pirson Y, Martin RS, Lifton RP, Tahvanainen E, Torres VE, Somlo S (2004) Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat Genet 36:575–577
Delmas P (2004) Polycystins: from mechanosensation to gene regulation. Cell 118:145–148
Delmas P (2005) Polycystins: polymodal receptor/ion-channel cellular sensors. Pflugers Arch 451:264–276
Delmas P, Padilla F, Osorio N, Coste B, Raoux M, Crest M (2004a) Polycystins, calcium signaling, and human diseases. Biochem Biophys Res Commun 322:1374–1383
Delmas P, Nauli SM, Li X, Coste B, Osorio N, Crest M, Brown DA, Zhou J (2004b) Gating of the polycystin ion channel signaling complex in neurons and kidney cells. FASEB J 18:740–742
Dessauer CW (2009) Adenylyl cyclase–A-kinase anchoring protein complexes: the next dimension in cAMP signaling. Mol Pharmacol 76:935–941
Drenth JPH, te Morsche RHM, Smink R, Bonifacino JS, Jansen JBMJ (2003) Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease. Nat Genet 33:345–347
Du J, Ding M, Sours-Brothers S, Graham S, Ma R (2008) Mediation of angiotensin II-induced Ca2+ signaling by polycystin 2 in glomerular mesangial cells. Am J Physiol Renal Physiol 294:F909–F918
Duning K, Rosenbusch D, Schlüter MA, Tian Y, Kunzelmann K, Meyer N, Schulze U, Markoff A, Pavenstädt H, Weide T (2010) Polycystin-2 activity is controlled by transcriptional coactivator with PDZ binding motif and PALS1-associated tight junction protein. J Biol Chem 285:33584–33588
European Polycystic Kidney Disease Consortium (1994) The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. The European Polycystic Kidney Disease Consortium. Cell 77:881–894
Fedeles SV, Tian X, Gallagher A, Mitobe M, Nishio S, Lee SH, Cai Y, Geng L, Crews CM, Somlo S (2011) A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation. Nat Genet 43:639–647
Feng S, Okenka GM, Bai CX, Streets AJ, Newby LJ, DeChant BT, Tsiokas L, Obara T, Ong AC (2008) Identification and functional characterization of an N-terminal oligomerization domain for polycystin-2. J Biol Chem 283:28471–28479
Feng S, Rodat-Despoix L, Delmas P, Ong ACM (2011) A single amino acid residue constitutes the third dimerization domain essential for the assembly and function of the tetrameric polycystin-2 (TRPP2) channel. J Biol Chem 286:18994–19000
Fick-Brosnahan GM, Belz MM, McFann KK, Johnson AM, Schrier RW (2002) Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study. Am J Kidney Dis 39:1127–1134
Field S, Riley K, Grimes DT, Hilton H, Simon M, Powles-Glover N, Siggers P, Bogani D, Greenfield A, Norris DP (2011) Pkd1l1 establishes left-right asymmetry and physically interacts with Pkd2. Development 138:1131–1142
Fogelgren B, Lin S, Zuo X, Jaffe KM, Park KM, Reichert RJ, Bell PD, Burdine RD, Lipschutz JH (2011) The exocyst protein Sec10 interacts with Polycystin-2 and knockdown causes PKD-phenotypes. PLoS Genet 7:e1001361
Fu X, Wang Y, Schetle N, Gao H, Pütz M, von Gersdorff G, Walz G, Kramer-Zucker AG (2008) The subcellular localization of TRPP2 modulates its function. J Am Soc Nephrol 19:1342–1351
Gabow PA, Chapman AB, Johnson AM, Tangel DJ, Duley IT, Kaehny WD, Manco-Johnson M, Schrier RW (1990) Renal structure and hypertension in autosomal dominant polycystic kidney disease. Kidney Int 38:1177–1180
Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, Jones RH (1992) Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 41:1311–1319
Gallagher AR, Cedzich A, Gretz N, Somlo S, Witzgall R (2000) The polycystic kidney disease protein PKD2 interacts with Hax-1, a protein associated with the actin cytoskeleton. Proc Natl Acad Sci USA 97:4017–4022
Gallio M, Ofstad TA, Macpherson LJ, Wang JW, Zuker CS (2011) The coding of temperature in the Drosophila brain. Cell 144:614–624
Gao Z, Ruden DM, Lu X (2003) PKD2 cation channel is required for directional sperm movement and male fertility. Curr Biol 13:2175–2178
Gao H, Wang Y, Wegierski T, Skouloudaki K, Pütz M, Fu X, Engel C, Boehlke C, Peng H, Kuehn EW, Kim E, Kramer-Zucker A, Walz G (2010) PRKCSH/80K-H, the protein mutated in polycystic liver disease, protects polycystin-2/TRPP2 against HERP-mediated degradation. Hum Mol Genet 19:16–24
Garcia-Gonzalez MA, Outeda P, Zhou Q, Zhou F, Menezes LF, Qian F, Huso DL, Germino GG, Piontek KB, Watnick T (2010) Pkd1 and Pkd2 are required for normal placental development. PLoS One 5(9):e12821
Geng L, Okuhara D, Yu Z, Tian X, Cai Y, Shibazaki S, Somlo S (2006) Polycystin-2 traffics to cilia independently of polycystin-1 by using an N-terminal RVxP motif. J Cell Sci 119:1383–1395
Geng L, Boehmerle W, Maeda Y, Okuhara DY, Tian X, Yu Z, Choe C, Anyatonwu GI, Ehrlich BE, Somlo S (2008) Syntaxin 5 regulates the endoplasmic reticulum channel-release properties of polycystin-2. Proc Natl Acad Sci USA 105:15920–15925
Giamarchi A, Padilla F, Coste B, Raoux M, Crest M, Honoré E, Delmas P (2006) The versatile nature of the calcium-permeable cation channel TRPP2. EMBO Rep 7:787–793
Giamarchi A, Feng S, Rodat-Despoix L, Xu Y, Bubenshchikova E, Newby LJ, Hao J, Gaudioso C, Crest M, Lupas AN, Honoré E, Williamson MP, Obara T, Ong ACM, Delmas P (2010) A polycystin-2 (TRPP2) dimerization domain essential for the function of heteromeric polycystin complexes. EMBO J 29:1176–1191
Goetz SC, Anderson KV (2010) The primary cilium: a signalling centre during vertebrate development. Nat Rev Genet 11:331–344
González-Perrett S, Kim K, Ibarra C, Damiano AE, Zotta E, Batelli M, Harris PC, Reisin IL, Arnaout MA, Cantiello HF (2001) Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. Proc Natl Acad Sci USA 98:1182–1187
González-Perrett S, Batelli M, Kim K, Essafi M, Timpanaro G, Moltabetti N, Reisin IL, Arnaout MA, Cantiello HF (2002) Voltage dependence and pH regulation of human polycystin-2-mediated cation channel activity. J Biol Chem 277:24959–24966
Grantham JJ (2008) Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med 359:1477–1485
Grantham JJ, Chapman AB, Torres VE (2006) Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. Clin J Am Soc Nephrol 1:148–157
Guo L, Chen M, Basora N, Zhou J (2000a) The human polycystic kidney disease 2-like (PKDL) gene: exon/intron structure and evidence for a novel splicing mechanism. Mamm Genome 11:46–50
Guo L, Schreiber TH, Weremowicz S, Morton CC, Lee C, Zhou J (2000b) Identification and characterization of a novel polycystin family member, polycystin-L2, in mouse and human: sequence, expression, alternative splicing, and chromosomal localization. Genomics 64:241–251
Hadimeri H, Lamm C, Nyberg G (1998) Coronary aneurysms in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 9:837–841
Hanaoka K, Guggino WB (2000) cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. J Am Soc Nephrol 11:1179–1187
Hanaoka K, Qian F, Boletta A, Bhunia AK, Piontek K, Tsiokas L, Sukhatme VP, Guggino WB, Germino GG (2000) Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 408:990–994
Harris PC, Torres VE (2009) Polycystic kidney disease. Annu Rev Med 60:321–337
Harris PC, Bae KT, Rossetti S, Torres VE, Grantham JJ, Chapman AB, Guay-Woodford LM, King BF, Wetzel LH, Baumgarten DA, Kenney PJ, Consugar M, Klahr S, Bennett WM, Meyers CM, Zhang QJ, Thompson PA, Zhu F, Miller JP (2006) Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 17:3013–3019
Hateboer N, v Dijk MA, Bogdanova N, Coto E, Saggar-Malik AK, San Millan JL, Torra R, Breuning M, Ravine D (1999) Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet 353:103–107
Hayashi T, Mochizuki T, Reynolds DM, Wu G, Cai Y, Somlo S (1997) Characterization of the exon structure of the polycystic kidney disease 2 gene (PKD2). Genomics 44:131–136
He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5:522–531
Hidaka S, Könecke V, Osten L, Witzgall R (2004) PIGEA-14, a novel coiled-coil protein affecting the intracellular distribution of polycystin-2. J Biol Chem 279:35009–35016
Hildebrandt F, Otto E (2005) Cilia and centrosomes: a unifying pathogenic concept for cystic kidney disease? Nat Rev Genet 6:928–940
Hildebrandt F, Benzing T, Katsanis N (2011) Ciliopathies. N Engl J Med 364:1533–1543
Hirokawa N, Tanaka Y, Okada Y, Takeda S (2006) Nodal flow and the generation of left-right asymmetry. Cell 125:33–45
Hoffert JD, Pisitkun T, Wang G, Shen R, Knepper MA (2006) Quantitative phosphoproteomics of vasopressin-sensitive renal cells: regulation of aquaporin-2 phosphorylation at two sites. Proc Natl Acad Sci USA 103:7159–7164
Hoffmeister H, Gallagher A, Rascle A, Witzgall R (2011a) The human polycystin-2 protein represents an integral membrane protein with six membrane-spanning domains and intracellular N- and C-termini. Biochem J 433:285–294
Hoffmeister H, Babinger K, Gürster S, Cedzich A, Meese C, Schadendorf K, Osten L, de Vries U, Rascle A, Witzgall R (2011b) Polycystin-2 takes different routes to the somatic and ciliary plasma membrane. J Cell Biol 192:631–645
Hofherr A (2012) The TRPP signaling module: TRPP2/polycystin-1 and TRPP2/PKD1L1. Methods Pharmacol Toxicol 2012:193–219
Hofherr A, Köttgen M (2011) TRPP channels and polycystins. Adv Exp Med Biol 704:287–313
Horio N, Yoshida R, Yasumatsu K, Yanagawa Y, Ishimaru Y, Matsunami H, Ninomiya Y (2011) Sour taste responses in mice lacking PKD channels. PLoS One 6:e20007
Hossack KF, Leddy CL, Johnson AM, Schrier RW, Gabow PA (1988) Echocardiographic findings in autosomal dominant polycystic kidney disease. N Engl J Med 319:907–912
Hsu PP, Kang SA, Rameseder J, Zhang Y, Ottina KA, Lim D, Peterson TR, Choi Y, Gray NS, Yaffe MB, Marto JA, Sabatini DM (2011) The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332:1317–1322
Hu J, Barr MM (2005) ATP-2 interacts with the PLAT domain of LOV-1 and is involved in Caenorhabditis. Mol Biol Cell 16:458–469
Huang AL, Chen X, Hoon MA, Chandrashekar J, Guo W, Tränkner D, Ryba NJP, Zuker CS (2006) The cells and logic for mammalian sour taste detection. Nature 442:934–938
Huang K, Diener DR, Mitchell A, Pazour GJ, Witman GB, Rosenbaum JL (2007) Function and dynamics of PKD2 in Chlamydomonas reinhardtii flagella. J Cell Biol 179:501–514
Huang YA, Maruyama Y, Stimac R, Roper SD (2008) Presynaptic (Type III) cells in mouse taste buds sense sour (acid) taste. J Physiol Lond 586:2903–2912
Hughes J, Ward CJ, Aspinwall R, Butler R, Harris PC (1999) Identification of a human homologue of the sea urchin receptor for egg jelly: a polycystic kidney disease-like protein. Hum Mol Genet 8:543–549
Hurd T, Zhou W, Jenkins P, Liu C, Swaroop A, Khanna H, Martens J, Hildebrandt F, Margolis B (2010) The retinitis pigmentosa protein RP2 interacts with polycystin 2 and regulates cilia-mediated vertebrate development. Hum Mol Genet 19:4330–4344
Huttlin EL, Jedrychowski MP, Elias JE, Goswami T, Rad R, Beausoleil SA, Villén J, Haas W, Sowa ME, Gygi SP (2010) A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143:1174–1189
International Polycystic Kidney Disease Consortium (1995) Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. The International Polycystic Kidney Disease Consortium. Cell 81:289–298
Ishimaru Y, Inada H, Kubota M, Zhuang H, Tominaga M, Matsunami H (2006) Transient receptor potential family members PKD1L3 and PKD2L1 form a candidate sour taste receptor. Proc Natl Acad Sci USA 103:12569–12574
Jahnel R, Dreger M, Gillen C, Bender O, Kurreck J, Hucho F (2001) Biochemical characterization of the vanilloid receptor 1 expressed in a dorsal root ganglia derived cell line. Eur J Biochem 268:5489–5496
Jurczyk A, Gromley A, Redick S, San Agustin J, Witman G, Pazour GJ, Peters DJM, Doxsey S (2004) Pericentrin forms a complex with intraflagellar transport proteins and polycystin-2 and is required for primary cilia assembly. J Cell Biol 166:637–643
Kamura K, Kobayashi D, Uehara Y, Koshida S, Iijima N, Kudo A, Yokoyama T, Takeda H (2011) Pkd1l1 complexes with Pkd2 on motile cilia and functions to establish the left-right axis. Development 138:1121–1129
Kedei N, Szabo T, Lile JD, Treanor JJ, Olah Z, Iadarola MJ, Blumberg PM (2001) Analysis of the native quaternary structure of vanilloid receptor 1. J Biol Chem 276:28613–28619
Kelleher CL, McFann KK, Johnson AM, Schrier RW (2004) Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population. Am J Hypertens 17:1029–1034
Khonsari RH, Ohazama A, Raouf R, Kawasaki M, Kawasaki K, Porntaveetus T, Ghafoor S, Hammond P, Suttie M, Odri GA, Sandford RN, Wood JN, Sharpe PT (2013) Multiple postnatal craniofacial anomalies are characterized by conditional loss of polycystic kidney disease 2 (Pkd2). Hum Mol Genet 22:1873–1885
Kim K, Drummond I, Ibraghimov-Beskrovnaya O, Klinger K, Arnaout MA (2000) Polycystin 1 is required for the structural integrity of blood vessels. Proc Natl Acad Sci USA 97:1731–1736
Kim I, Fu Y, Hui K, Moeckel G, Mai W, Li C, Liang D, Zhao P, Ma J, Chen XZ, George AL Jr, Coffey RJ, Feng ZP, Wu G (2008) Fibrocystin/polyductin modulates renal tubular formation by regulating polycystin-2 expression and function. J Am Soc Nephrol 19:455–468
Kimberling WJ, Fain PR, Kenyon JB, Goldgar D, Sujansky E, Gabow PA (1988) Linkage heterogeneity of autosomal dominant polycystic kidney disease. N Engl J Med 319:913–918
King BF, Reed JE, Bergstralh EJ, Sheedy PF, Torres VE (2000) Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 11:1505–1511
Kobori T, Smith GD, Sandford R, Edwardson JM (2009) The transient receptor potential channels TRPP2 and TRPC1 form a heterotetramer with a 2:2 stoichiometry and an alternating subunit arrangement. J Biol Chem 284:35507–35513
Kotsis F, Boehlke C, Kuehn EW (2013) The ciliary flow sensor and polycystic kidney disease. Nephrol Dial Transplant 28:518–526
Köttgen M (2007) TRPP2 and autosomal dominant polycystic kidney disease. Biochim Biophys Acta 1772:836–850
Köttgen M, Walz G (2005) Subcellular localization and trafficking of polycystins. Pflugers Arch 451:286–293
Köttgen M, Benzing T, Simmen T, Tauber R, Buchholz B, Feliciangeli S, Huber TB, Schermer B, Kramer-Zucker A, Höpker K, Simmen KC, Tschucke CC, Sandford R, Kim E, Thomas G, Walz G (2005) Trafficking of TRPP2 by PACS proteins represents a novel mechanism of ion channel regulation. EMBO J 24:705–716
Köttgen M, Buchholz B, Garcia-Gonzalez MA, Kotsis F, Fu X, Doerken M, Boehlke C, Steffl D, Tauber R, Wegierski T, Nitschke R, Suzuki M, Kramer-Zucker A, Germino GG, Watnick T, Prenen J, Nilius B, Kuehn EW, Walz G (2008) TRPP2 and TRPV4 form a polymodal sensory channel complex. J Cell Biol 182:437–447
Köttgen M, Hofherr A, Li W, Chu K, Cook S, Montell C, Watnick T (2011) Drosophila sperm swim backwards in the female reproductive tract and are activated via TRPP2 ion channels. PLoS One 6:e20031
Koulen P, Cai Y, Geng L, Maeda Y, Nishimura S, Witzgall R, Ehrlich BE, Somlo S (2002) Polycystin-2 is an intracellular calcium release channel. Nat Cell Biol 4:191–197
Kuehn EW, Park KM, Somlo S, Bonventre JV (2002) Kidney injury molecule-1 expression in murine polycystic kidney disease. Am J Physiol Renal Physiol 283:F1326–F1336
Langenhan T, Aust G, Hamann J (2013) Sticky signaling–adhesion class g protein-coupled receptors take the stage. Sci Signal 6:re3
Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23:2947–2948
Lehtonen S, Ora A, Olkkonen VM, Geng L, Zerial M, Somlo S, Lehtonen E (2000) In vivo interaction of the adapter protein CD2-associated protein with the type 2 polycystic kidney disease protein, polycystin-2. J Biol Chem 275:32888–32893
Leung GKK, Fan YW (2005) Chronic subdural haematoma and arachnoid cyst in autosomal dominant polycystic kidney disease (ADPKD). J Clin Neurosci 12:817–819
Li A, Tian X, Sung S, Somlo S (2003a) Identification of two novel polycystic kidney disease-1-like genes in human and mouse genomes. Genomics 81:596–608
Li Q, Dai Y, Guo L, Liu Y, Hao C, Wu G, Basora N, Michalak M, Chen XZ (2003b) Polycystin-2 associates with tropomyosin-1, an actin microfilament component. J Mol Biol 325:949–962
Li Q, Liu Y, Shen PY, Dai XQ, Wang S, Smillie LB, Sandford R, Chen XZ (2003c) Troponin I binds polycystin-L and inhibits its calcium-induced channel. Biochemistry 42:7618–7625
Li Q, Shen PY, Wu G, Chen XZ (2003d) Polycystin-2 interacts with troponin I, an angiogenesis inhibitor. Biochemistry 42:450–457
Li X, Luo Y, Starremans PG, McNamara CA, Pei Y, Zhou J (2005a) Polycystin-1 and polycystin-2 regulate the cell cycle through the helix-loop-helix inhibitor Id2. Nat Cell Biol 7:1202–1212
Li Y, Wright JM, Qian F, Germino GG, Guggino WB (2005b) Polycystin 2 interacts with type I inositol 1,4,5-trisphosphate receptor to modulate intracellular Ca2+ signaling. J Biol Chem 280:41298–41306
Li Q, Montalbetti N, Shen PY, Dai X, Cheeseman CI, Karpinski E, Wu G, Cantiello HF, Chen X (2005c) Alpha-actinin associates with polycystin-2 and regulates its channel activity. Hum Mol Genet 14:1587–1603
Li Q, Montalbetti N, Wu Y, Ramos A, Raychowdhury MK, Chen X, Cantiello HF (2006) Polycystin-2 cation channel function is under the control of microtubular structures in primary cilia of renal epithelial cells. J Biol Chem 281:37566–37575
Li Q, Dai X, Shen PY, Wu Y, Long W, Chen CX, Hussain Z, Wang S, Chen X (2007) Direct binding of alpha-actinin enhances TRPP3 channel activity. J Neurochem 103:2391–2400
Li X, Magenheimer BS, Xia S, Johnson T, Wallace DP, Calvet JP, Li R (2008) A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant. Nat Med 14:863–868
Li M, Yu Y, Yang J (2011) Structural biology of TRP channels. Adv Exp Med Biol 704:1–23
Liang G, Yang J, Wang Z, Li Q, Tang Y, Chen X (2008a) Polycystin-2 down-regulates cell proliferation via promoting PERK-dependent phosphorylation of eIF2alpha. Hum Mol Genet 17:3254–3262
Liang G, Li Q, Tang Y, Kokame K, Kikuchi T, Wu G, Chen X (2008b) Polycystin-2 is regulated by endoplasmic reticulum-associated degradation. Hum Mol Genet 17:1109–1119
Lin F, Hiesberger T, Cordes K, Sinclair AM, Goldstein LSB, Somlo S, Igarashi P (2003) Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease. Proc Natl Acad Sci USA 100:5286–5291
Longo DL, Harrison TR (2012) Harrison’s principles of internal medicine. McGraw-Hill, New York
Lopezjimenez ND, Cavenagh MM, Sainz E, Cruz-Ithier MA, Battey JF, Sullivan SL (2006) Two members of the TRPP family of ion channels, Pkd1l3 and Pkd2l1, are co-expressed in a subset of taste receptor cells. J Neurochem 98:68–77
Lu W, Peissel B, Babakhanlou H, Pavlova A, Geng L, Fan X, Larson C, Brent G, Zhou J (1997) Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation. Nat Genet 17:179–181
Lu W, Fan X, Basora N, Babakhanlou H, Law T, Rifai N, Harris PC, Perez-Atayde AR, Rennke HG, Zhou J (1999) Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes. Nat Genet 21:160–161
Lu W, Shen X, Pavlova A, Lakkis M, Ward CJ, Pritchard L, Harris PC, Genest DR, Perez-Atayde AR, Zhou J (2001) Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects. Hum Mol Genet 10:2385–2396
Lumiaho A, Ikäheimo R, Miettinen R, Niemitukia L, Laitinen T, Rantala A, Lampainen E, Laakso M, Hartikainen J (2001) Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1. Am J Kidney Dis 38:1208–1216
Luo Y, Vassilev PM, Li X, Kawanabe Y, Zhou J (2003) Native polycystin 2 functions as a plasma membrane Ca2+-permeable cation channel in renal epithelia. Mol Cell Biol 23:2600–2607
Lyall V, Alam RI, Phan DQ, Ereso GL, Phan TH, Malik SA, Montrose MH, Chu S, Heck GL, Feldman GM, DeSimone JA (2001) Decrease in rat taste receptor cell intracellular pH is the proximate stimulus in sour taste transduction. Am J Physiol Cell Physiol 281:C1005–C1013
Ma R, Li W, Rundle D, Kong J, Akbarali HI, Tsiokas L (2005) PKD2 functions as an epidermal growth factor-activated plasma membrane channel. Mol Cell Biol 25:8285–8298
Magistroni R, He N, Wang K, Andrew R, Johnson A, Gabow P, Dicks E, Parfrey P, Torra R, San-Millan JL, Coto E, van Dijk M, Breuning M, Peters D, Bogdanova N, Ligabue G, Albertazzi A, Hateboer N, Demetriou K, Pierides A, Deltas C, St George-Hyslop P, Ravine D, Pei Y (2003) Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease. J Am Soc Nephrol 14:1164–1174
McGrath J, Somlo S, Makova S, Tian X, Brueckner M (2003) Two populations of node monocilia initiate left-right asymmetry in the mouse. Cell 114:61–73
Mekahli D, Sammels E, Luyten T, Welkenhuyzen K, van den Heuvel LP, Levtchenko EN, Gijsbers R, Bultynck G, Parys JB, de Smedt H, Missiaen L (2012) Polycystin-1 and polycystin-2 are both required to amplify inositol-trisphosphate-induced Ca2+ release. Cell Calcium 51:452–458
Menezes LF, Germino GG (2009) Polycystic kidney disease, cilia, and planar polarity. Methods Cell Biol 94:273–297
Miyagi K, Kiyonaka S, Yamada K, Miki T, Mori E, Kato K, Numata T, Sawaguchi Y, Numaga T, Kimura T, Kanai Y, Kawano M, Wakamori M, Nomura H, Koni I, Yamagishi M, Mori Y (2009) A pathogenic C terminus-truncated polycystin-2 mutant enhances receptor-activated Ca2+ entry via association with TRPC3 and TRPC7. J Biol Chem 284:34400–34412
Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, Reynolds DM, Cai Y, Gabow PA, Pierides A, Kimberling WJ, Breuning MH, Deltas CC, Peters DJ, Somlo S (1996) PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272:1339–1342
Moiseenkova-Bell VY, Stanciu LA, Serysheva II, Tobe BJ, Wensel TG (2008) Structure of TRPV1 channel revealed by electron cryomicroscopy. Proc Natl Acad Sci USA 105:7451–7455
Molina H, Horn DM, Tang N, Mathivanan S, Pandey A (2007) Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry. Proc Natl Acad Sci USA 104:2199–2204
Molland KL, Paul LN, Yernool DA (1824) Crystal structure and characterization of coiled-coil domain of the transient receptor potential channel PKD2L1. Biochim Biophys Acta 2012:413–421
Molland KL, Narayanan A, Burgner JW, Yernool DA (2010) Identification of the structural motif responsible for trimeric assembly of the C-terminal regulatory domains of polycystin channels PKD2L1 and PKD2. Biochem J 429:171–183
Moremen KW, Tiemeyer M, Nairn AV (2012) Vertebrate protein glycosylation: diversity, synthesis and function. Nat Rev Mol Cell Biol 13:448–462
Murakami M, Ohba T, Xu F, Shida S, Satoh E, Ono K, Miyoshi I, Watanabe H, Ito H, Iijima T (2005) Genomic organization and functional analysis of murine PKD2L1. J Biol Chem 280:5626–5635
Muto S, Aiba A, Saito Y, Nakao K, Nakamura K, Tomita K, Kitamura T, Kurabayashi M, Nagai R, Higashihara E, Harris PC, Katsuki M, Horie S (2002) Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1. Hum Mol Genet 11:1731–1742
Nauli SM, Zhou J (2004) Polycystins and mechanosensation in renal and nodal cilia. Bioessays 26:844–856
Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, Li X, Elia AEH, Lu W, Brown EM, Quinn SJ, Ingber DE, Zhou J (2003) Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet 33:129–137
Neill AT, Moy GW, Vacquier VD (2004) Polycystin-2 associates with the polycystin-1 homolog, suREJ3, and localizes to the acrosomal region of sea urchin spermatozoa. Mol Reprod Dev 67:472–477
Nelson TM, Lopezjimenez ND, Tessarollo L, Inoue M, Bachmanov AA, Sullivan SL (2010) Taste function in mice with a targeted mutation of the Pkd1l3 gene. Chem Senses 35(7):565–577
Newby LJ, Streets AJ, Zhao Y, Harris PC, Ward CJ, Ong AC (2002) Identification, characterization, and localization of a novel kidney polycystin-1-polycystin-2 complex. J Biol Chem 277:20763–20773
Nilius B, Owsianik G (2011) The transient receptor potential family of ion channels. Genome Biol 12:218
Nilius B, Voets T, Peters J (2005) TRP channels in disease. Sci STKE 2005:re8
Nomura H, Turco AE, Pei Y, Kalaydjieva L, Schiavello T, Weremowicz S, Ji W, Morton CC, Meisler M, Reeders ST, Zhou J (1998) Identification of PKDL, a novel polycystic kidney disease 2-like gene whose murine homologue is deleted in mice with kidney and retinal defects. J Biol Chem 273:25967–25973
Norris DP, Grimes DT (2012) Developmental biology. Cilia discern left from right. Science 338:206–207
Ohta Y, Hartwig JH, Stossel TP (2006) FilGAP, a Rho- and ROCK-regulated GAP for Rac binds filamin A to control actin remodelling. Nat Cell Biol 8:803–814
Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M (2006) Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127:635–648
Orts-Del'immagine A, Wanaverbecq N, Tardivel C, Tillement V, Dallaporta M, Trouslard J (2012) Properties of subependymal cerebrospinal fluid contacting neurones in the dorsal vagal complex of the mouse brainstem. J Physiol Lond 590:3719–3741
Palmer CP, Aydar E, Djamgoz MBA (2005) A microbial TRP-like polycystic-kidney-disease-related ion channel gene. Biochem J 387:211–219
Patel V, Williams D, Hajarnis S, Hunter R, Pontoglio M, Somlo S, Igarashi P (2013) miR-17 92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease. Proc Natl Acad Sci USA 110(26):10765–10770
Paterson AD, Pei Y (1998) Is there a third gene for autosomal dominant polycystic kidney disease? Kidney Int 54:1759–1761
Paterson AD, Wang KR, Lupea D, St George-Hyslop P, Pei Y (2002) Recurrent fetal loss associated with bilineal inheritance of type 1 autosomal dominant polycystic kidney disease. Am J Kidney Dis 40:16–20
Paul BM, Consugar MB, Ryan Lee M, Sundsbak JL, Heyer CM, Rossetti S, Kubly VJ, Hopp K, Torres VE, Coto E, Clementi M, Bogdanova N, de Almeida E, Bichet DG, Harris PC (2014) Evidence of a third ADPKD locus is not supported by re-analysis of designated PKD3 families. Kidney Int 85(2):383–392
Pazour GJ, Dickert BL, Vucica Y, Seeley ES, Rosenbaum JL, Witman GB, Cole DG (2000) Chlamydomonas IFT88 and its mouse homologue, polycystic kidney disease gene tg737, are required for assembly of cilia and flagella. J Cell Biol 151:709–718
Pazour GJ, San Agustin JT, Follit JA, Rosenbaum JL, Witman GB (2002) Polycystin-2 localizes to kidney cilia and the ciliary level is elevated in orpk mice with polycystic kidney disease. Curr Biol 12:R378–R380
Pei Y (2001) A “two-hit” model of cystogenesis in autosomal dominant polycystic kidney disease? Trends Mol Med 7:151–156
Pei Y, Paterson AD, Wang KR, He N, Hefferton D, Watnick T, Germino GG, Parfrey P, Somlo S, St George-Hyslop P (2001) Bilineal disease and trans-heterozygotes in autosomal dominant polycystic kidney disease. Am J Hum Genet 68:355–363
Pennekamp P, Karcher C, Fischer A, Schweickert A, Skryabin B, Horst J, Blum M, Dworniczak B (2002) The ion channel polycystin-2 is required for left-right axis determination in mice. Curr Biol 12:938–943
Persu A, Duyme M, Pirson Y, Lens XM, Messiaen T, Breuning MH, Chauveau D, Levy M, Grünfeld J, Devuyst O (2004) Comparison between siblings and twins supports a role for modifier genes in ADPKD. Kidney Int 66:2132–2136
Peters DJ, Sandkuijl LA (1992) Genetic heterogeneity of polycystic kidney disease in Europe. Contrib Nephrol 97:128–139
Petri ET, Ćelić A, Kennedy SD, Ehrlich BE, Boggon TJ, Hodsdon ME (2010) Structure of the EF-hand domain of polycystin-2 suggests a mechanism for Ca2+-dependent regulation of polycystin-2 channel activity. Proc Natl Acad Sci USA 107:9176–9181
Piontek KB, Huso DL, Grinberg A, Liu L, Bedja D, Zhao H, Gabrielson K, Qian F, Mei C, Westphal H, Germino GG (2004) A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo. J Am Soc Nephrol 15:3035–3043
Piontek K, Menezes LF, Garcia-Gonzalez MA, Huso DL, Germino GG (2007) A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat Med 13:1490–1495
Plotnikova OV, Pugacheva EN, Golemis EA (2011) Aurora A kinase activity influences calcium signaling in kidney cells. J Cell Biol 193:1021–1032
Praetorius HA, Spring KR (2001) Bending the MDCK cell primary cilium increases intracellular calcium. J Membr Biol 184:71–79
Praetorius HA, Spring KR (2005) A physiological view of the primary cilium. Annu Rev Physiol 67:515–529
Prasad S, McDaid JP, Tam FW, Haylor JL, Ong AC (2009) Pkd2 dosage influences cellular repair responses following ischemia-reperfusion. Am J Pathol 175:1493–1503
Qian F, Noben-Trauth K (2005) Cellular and molecular function of mucolipins (TRPML) and polycystin 2 (TRPP2). Pflugers Arch 451:277–285
Qian F, Watnick TJ, Onuchic LF, Germino GG (1996) The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell 87:979–987
Qian F, Germino FJ, Cai Y, Zhang X, Somlo S, Germino GG (1997) PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat Genet 16:179–183
Qian F, Boletta A, Bhunia AK, Xu H, Liu L, Ahrabi AK, Watnick TJ, Zhou F, Germino GG (2002) Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations. Proc Natl Acad Sci USA 99:16981–16986
Raychowdhury MK, McLaughlin M, Ramos AJ, Montalbetti N, Bouley R, Ausiello DA, Cantiello HF (2005) Characterization of single channel currents from primary cilia of renal epithelial cells. J Biol Chem 280:34718–34722
Reeders ST (1992) Multilocus polycystic disease. Nat Genet 1:235–237
Reeders ST, Breuning MH, Davies KE, Nicholls RD, Jarman AP, Higgs DR, Pearson PL, Weatherall DJ (1985) A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature 317:542–544
Rosenbaum JL, Witman GB (2002) Intraflagellar transport. Nat Rev Mol Cell Biol 3:813–825
Rossetti S, Burton S, Strmecki L, Pond GR, San Millán JL, Zerres K, Barratt TM, Ozen S, Torres VE, Bergstralh EJ, Winearls CG, Harris PC (2002) The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. J Am Soc Nephrol 13:1230–1237
Rundle DR, Gorbsky G, Tsiokas L (2004) PKD2 interacts and co-localizes with mDia1 to mitotic spindles of dividing cells: role of mDia1 IN PKD2 localization to mitotic spindles. J Biol Chem 279:29728–29739
Sammels E, Devogelaere B, Mekahli D, Bultynck G, Missiaen L, Parys JB, Cai Y, Somlo S, de Smedt H (2010) Polycystin-2 activation by inositol 1,4,5-trisphosphate-induced Ca2+ release requires its direct association with the inositol 1,4,5-trisphosphate receptor in a signaling microdomain. J Biol Chem 285:18794–18805
Scheffers MS, Le H, van der Bent P, Leonhard W, Prins F, Spruit L, Breuning MH, de Heer E, Peters DJM (2002) Distinct subcellular expression of endogenous polycystin-2 in the plasma membrane and Golgi apparatus of MDCK cells. Hum Mol Genet 11:59–67
Schievink WI, Huston J, Torres VE, Marsh WR (1995) Intracranial cysts in autosomal dominant polycystic kidney disease. J Neurosurg 83:1004–1007
Schottenfeld J, Sullivan-Brown J, Burdine RD (2007) Zebrafish curly up encodes a Pkd2 ortholog that restricts left-side-specific. Development 134:1605–1615
Sharif-Naeini R, Folgering JHA, Bichet D, Duprat F, Lauritzen I, Arhatte M, Jodar M, Dedman A, Chatelain FC, Schulte U, Retailleau K, Loufrani L, Patel A, Sachs F, Delmas P, Peters DJM, Honoré E (2009) Polycystin-1 and -2 dosage regulates pressure sensing. Cell 139:587–596
Shimizu T, Janssens A, Voets T, Nilius B (2009) Regulation of the murine TRPP3 channel by voltage, pH, and changes in cell volume. Pflugers Arch 457:795–807
Shimizu T, Higuchi T, Fujii T, Nilius B, Sakai H (2011) Bimodal effect of alkalization on the polycystin transient receptor potential channel, PKD2L1. Pflugers Arch 461:507–513
Sohara E, Luo Y, Zhang J, Manning DK, Beier DR, Zhou J (2008) Nek8 regulates the expression and localization of polycystin-1 and polycystin-2. J Am Soc Nephrol 19:469–476
Somlo S (1999) The PKD2 gene: structure, interactions, mutations, and inactivation. Adv Nephrol Necker Hosp 29:257–275
Somlo S, Ehrlich B (2001) Human disease: calcium signaling in polycystic kidney disease. Curr Biol 11:R356–R360
Stewart AP, Smith GD, Sandford RN, Edwardson JM (2010) Atomic force microscopy reveals the alternating subunit arrangement of the TRPP2-TRPV4 heterotetramer. Biophys J 99:790–797
Streets AJ, Moon DJ, Kane ME, Obara T, Ong ACM (2006) Identification of an N-terminal glycogen synthase kinase 3 phosphorylation site which regulates the functional localization of polycystin-2 in vivo and in vitro. Hum Mol Genet 15:1465–1473
Streets AJ, Needham AJ, Gill SK, Ong ACM (2010) Protein kinase D-mediated phosphorylation of polycystin-2 (TRPP2) is essential for its effects on cell growth and calcium channel activity. Mol Biol Cell 21:3853–3865
Streets AJ, Wessely O, Peters DJM, Ong ACM (2013) Hyperphosphorylation of polycystin-2 at a critical residue in disease reveals an essential role for polycystin-1-regulated dephosphorylation. Hum Mol Genet 22:1924–1939
Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 101:6062–6067
Sun Z, Amsterdam A, Pazour GJ, Cole DG, Miller MS, Hopkins N (2004) A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney. Development 131:4085–4093
Sun H, Li QW, Lv XY, Ai JZ, Yang QT, Duan JJ, Bian GH, Xiao Y, Wang YD, Zhang Z, Liu YH, Tan RZ, Yang Y, Wei YQ, Zhou Q (2010) MicroRNA-17 post-transcriptionally regulates polycystic kidney disease-2 gene and promotes cell proliferation. Mol Biol Rep 37(6):2951–2958
Sutton KA, Jungnickel MK, Ward CJ, Harris PC, Florman HM (2006) Functional characterization of PKDREJ, a male germ cell-restricted polycystin. J Cell Physiol 209:493–500
Taft RA, Denegre JM, Pendola FL, Eppig JJ (2002) Identification of genes encoding mouse oocyte secretory and transmembrane proteins by a signal sequence trap. Biol Reprod 67:953–960
Takakura A, Contrino L, Zhou X, Bonventre JV, Sun Y, Humphreys BD, Zhou J (2009) Renal injury is a third hit promoting rapid development of adult polycystic. Hum Mol Genet 18:2523–2531
Tarrant MK, Cole PA (2009) The chemical biology of protein phosphorylation. Annu Rev Biochem 78:797–825
Tian Y, Kolb R, Hong J, Carroll J, Li D, You J, Bronson R, Yaffe MB, Zhou J, Benjamin T (2007) TAZ promotes PC2 degradation through a SCFbeta-Trcp E3 ligase complex. Mol Cell Biol 27:6383–6395
Torra R, Badenas C, Darnell A, Nicolau C, Volpini V, Revert L, Estivill X (1996) Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2. J Am Soc Nephrol 7:2142–2151
Torres VE, Harris PC (2009) Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int 76:149–168
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS (2012) Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 367:2407–2418
Tran U, Zakin L, Schweickert A, Agrawal R, Döger R, Blum M, de Robertis EM, Wessely O (2010) The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity. Development 137:1107–1116
Tsiokas L (2009) Function and regulation of TRPP2 at the plasma membrane. Am J Physiol Renal Physiol 297:F1–F9
Tsiokas L, Kim E, Arnould T, Sukhatme VP, Walz G (1997) Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc Natl Acad Sci USA 94:6965–6970
Tsiokas L, Arnould T, Zhu C, Kim E, Walz G, Sukhatme VP (1999) Specific association of the gene product of PKD2 with the TRPC1 channel. Proc Natl Acad Sci USA 96:3934–3939
U.S. Renal Data System, (2011) Annual data report: Atlas of end-stage renal disease in the United States. National Institutes of Health, Bethesda, MD
U.S. Renal Data System (2012) USRDS, annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, Bethesda, MD
Vassilev PM, Guo L, Chen XZ, Segal Y, Peng JB, Basora N, Babakhanlou H, Cruger G, Kanazirska M (2001) Ye Cp, Brown EM, Hediger MA, Zhou J. Polycystin-2 is a novel cation channel implicated in defective intracellular Ca(2+) homeostasis in polycystic kidney disease. Biochem Biophys Res Commun 282:341–350
Veldhuisen B, Spruit L, Dauwerse HG, Breuning MH, Peters DJ (1999) Genes homologous to the autosomal dominant polycystic kidney disease genes (PKD1 and PKD2). Eur J Hum Genet 7:860–872
Venkatachalam K, Montell C (2007) TRP channels. Annu Rev Biochem 76:387–417
Vogel P, Read R, Hansen GM, Freay LC, Zambrowicz BP, Sands AT (2010) Situs inversus in Dpcd/Poll-/-, Nme7-/-, and Pkd1l1-/- mice. Vet Pathol 47:120–131
Volk T, Schwoerer AP, Thiessen S, Schultz J, Ehmke H (2003) A polycystin-2-like large conductance cation channel in rat left ventricular myocytes. Cardiovasc Res 58:76–88
Voronina VA, Takemaru K, Treuting P, Love D, Grubb BR, Hajjar AM, Adams A, Li F, Moon RT (2009) Inactivation of Chibby affects function of motile airway cilia. J Cell Biol 185:225–233
Wang Q, Dai X, Li Q, Wang Z, Cantero Mdel R, Li S, Shen J, Tu J, Cantiello H, Chen X (2012) Structural interaction and functional regulation of polycystin-2 by filamin. PLoS One 7:e40448
Watnick TJ, Torres VE, Gandolph MA, Qian F, Onuchic LF, Klinger KW, Landes G, Germino GG (1998) Somatic mutation in individual liver cysts supports a two-hit model of cystogenesis in autosomal dominant polycystic kidney disease. Mol Cell 2:247–251
Watnick TJ, Jin Y, Matunis E, Kernan MJ, Montell C (2003) A flagellar polycystin-2 homolog required for male fertility in Drosophila. Curr Biol 13:2179–2184
Wegierski T, Steffl D, Kopp C, Tauber R, Buchholz B, Nitschke R, Kuehn EW, Walz G, Köttgen M (2009) TRPP2 channels regulate apoptosis through the Ca2+ concentration in the endoplasmic reticulum. EMBO J 28:490–499
Wei W, Hackmann K, Xu H, Germino G, Qian F (2007) Characterization of cis-autoproteolysis of polycystin-1, the product of human polycystic kidney disease 1 gene. J Biol Chem 282:21729–21737
Wickstead B, Gull K (2011) The evolution of the cytoskeleton. J Cell Biol 194:513–525
Wijdicks EF, Torres VE, Schievink WI (2000) Chronic subdural hematoma in autosomal dominant polycystic kidney disease. Am J Kidney Dis 35:40–43
Wilson PD (2008) Mouse models of polycystic kidney disease. Curr Top Dev Biol 84:311–350
Witzgall R (2005) Polycystin-2–an intracellular or plasma membrane channel? Naunyn Schmiedebergs Arch Pharmacol 371:342–347
Wodarczyk C, Distefano G, Rowe I, Gaetani M, Bricoli B, Muorah M, Spitaleri A, Mannella V, Ricchiuto P, Pema M, Castelli M, Casanova AE, Mollica L, Banzi M, Boca M, Antignac C, Saunier S, Musco G, Boletta A (2010) Nephrocystin-1 forms a complex with polycystin-1 via a polyproline motif/SH3 domain interaction and regulates the apoptotic response in mammals. PLoS One 5:e12719
Wong W, Scott JD (2004) AKAP signalling complexes: focal points in space and time. Nat Rev Mol Cell Biol 5:959–970
Woudenberg-Vrenken TE, Bindels RJM, Hoenderop JGJ (2009) The role of transient receptor potential channels in kidney disease. Nat Rev Nephrol 5:441–449
Wu G, Hayashi T, Park JH, Dixit M, Reynolds DM, Li L, Maeda Y, Cai Y, Coca-Prados M, Somlo S (1998a) Identification of PKD2L, a human PKD2-related gene: tissue-specific expression and mapping to chromosome 10q25. Genomics 54:564–568
Wu G, D’Agati V, Cai Y, Markowitz G, Park JH, Reynolds DM, Maeda Y, Le TC, Hou H, Kucherlapati R, Edelmann W, Somlo S (1998b) Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 93:177–188
Wu G, Markowitz GS, Li L, D’Agati VD, Factor SM, Geng L, Tibara S, Tuchman J, Cai Y, Park JH, van Adelsberg J, Hou H, Kucherlapati R, Edelmann W, Somlo S (2000) Cardiac defects and renal failure in mice with targeted mutations in Pkd2. Nat Genet 24:75–78
Wu G, Tian X, Nishimura S, Markowitz GS, D’Agati V, Park JH, Yao L, Li L, Geng L, Zhao H, Edelmann W, Somlo S (2002) Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease. Hum Mol Genet 11:1845–1854
Wu Y, Dai X, Li Q, Chen CX, Mai W, Hussain Z, Long W, Montalbetti N, Li G, Glynne R, Wang S, Cantiello HF, Wu G, Chen X (2006) Kinesin-2 mediates physical and functional interactions between polycystin-2 and fibrocystin. Hum Mol Genet 15:3280–3292
Wu C, Orozco C, Boyer J, Leglise M, Goodale J, Batalov S, Hodge CL, Haase J, Janes J, Huss JW, Su AI (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 10:R130
Yang Y, Cochran DA, Gargano MD, King I, Samhat NK, Burger BP, Sabourin KR, Hou Y, Awata J, Parry DAD, Marshall WF, Witman GB, Lu X (2011) Regulation of flagellar motility by the conserved flagellar protein CG34110/Ccdc135/FAP50. Mol Biol Cell 22:976–987
Yang J, Wang Q, Zheng W, Tuli J, Li Q, Wu Y, Hussein S, Dai X, Shafiei S, Li X, Shen PY, Tu J, Chen X (2012) Receptor for activated C kinase 1 (RACK1) inhibits function of transient receptor potential (TRP)-type channel Pkd2L1 through physical interaction. J Biol Chem 287:6551–6561
Ye C, Sun H, Guo W, Wei Y, Zhou Q (2009) Molecular evolution of PKD2 gene family in mammals. Genetica 137:77–86
Yoder BK, Richards WG, Sommardahl C, Sweeney WE, Michaud EJ, Wilkinson JE, Avner ED, Woychik RP (1996) Functional correction of renal defects in a mouse model for ARPKD through expression of the cloned wild-type Tg737 cDNA. Kidney Int 50:1240–1248
Yoder BK, Hou X, Guay-Woodford LM (2002) The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. J Am Soc Nephrol 13:2508–2516
Yoshiba S, Shiratori H, Kuo IY, Kawasumi A, Shinohara K, Nonaka S, Asai Y, Sasaki G, Belo JA, Sasaki H, Nakai J, Dworniczak B, Ehrlich BE, Pennekamp P, Hamada H (2012) Cilia at the node of mouse embryos sense fluid flow for left-right determination via Pkd2. Science 338:226–231
Yu S, Hackmann K, Gao J, Gao J, He X, Piontek K, García-González MA, García González MA, Menezes LF, Xu H, Germino GG, Zuo J, Qian F (2007) Essential role of cleavage of Polycystin-1 at G protein-coupled receptor proteolytic site for kidney tubular structure. Proc Natl Acad Sci USA 104:18688–18693
Yu Y, Ulbrich MH, Li M, Buraei Z, Chen X, Ong ACM, Tong L, Isacoff EY, Yang J (2009) Structural and molecular basis of the assembly of the TRPP2/PKD1 complex. Proc Natl Acad Sci USA 106:11558–11563
Yu Y, Ulbrich MH, Li M, Dobbins S, Zhang WK, Tong L, Isacoff EY, Yang J (2012) Molecular mechanism of the assembly of an acid-sensing receptor ion channel complex. Nat Commun 3:1252
Yuasa T, Venugopal B, Weremowicz S, Morton CC, Guo L, Zhou J (2002) The sequence, expression, and chromosomal localization of a novel polycystic kidney disease 1-like gene, PKD1L1, in human. Genomics 79:376–386
Zanivan S, Gnad F, Wickström SA, Geiger T, Macek B, Cox J, Fässler R, Mann M (2008) Solid tumor proteome and phosphoproteome analysis by high resolution mass spectrometry. J Proteome Res 7:5314–5326
Zhang Y, Wada J, Yasuhara A, Iseda I, Eguchi J, Fukui K, Yang Q, Yamagata K, Hiesberger T, Igarashi P, Zhang H, Wang H, Akagi S, Kanwar YS, Makino H (2007) The role for HNF-1beta-targeted collectrin in maintenance of primary cilia and cell polarity in collecting duct cells. PLoS One 2:e414
Zhou J (2009) Polycystins and primary cilia: primers for cell cycle progression. Annu Rev Physiol 71:83–113
Zhou A, Hartwig JH, Akyürek LM (2010) Filamins in cell signaling, transcription and organ development. Trends Cell Biol 20:113–123
Acknowledgments
Since the initial description of TRPP proteins, the accelerated pace of scientific discovery has produced an impressive body of knowledge. The authors apologise to those whose work could not be cited due to space limitations. Funding was awarded by the Deutsche Forschungsgemeinschaft (DFG KFO 201), by the Excellence Initiative of the German Federal and State Governments (GSC-4, Spemann Graduate School) and by the Alfried Krupp von Bohlen und Halbach Foundation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Semmo, M., Köttgen, M., Hofherr, A. (2014). The TRPP Subfamily and Polycystin-1 Proteins. In: Nilius, B., Flockerzi, V. (eds) Mammalian Transient Receptor Potential (TRP) Cation Channels. Handbook of Experimental Pharmacology, vol 222. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54215-2_27
Download citation
DOI: https://doi.org/10.1007/978-3-642-54215-2_27
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-54214-5
Online ISBN: 978-3-642-54215-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)